{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.1",
    "document_metadata": {
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "The Biology of Proteostasis in Aging and Disease",
      "version": "1.0.0",
      "authors": "Esther Wollert",
      "description": ""
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/cf4d8bb88754f036b943b4d94ad96e103dcb7149/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$",
      "PUBCHEM": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_list": {},
    "path": "/Users/cthoyt/dev/hbp-knowledge/hbp_knowledge/morimoto2015.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "N-retinylidene-N-retinylethanolamine",
      "id": "39d6d1f63226a54177cf597f62bec75145297c58206aad7f8d5c07436074904aaf4630dcc1ebad742fd971beb6167df696c3a2cf8655725650af9867dcc02a14"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "amyloid-beta",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "chloroquine",
      "id": "54ff8c0fd55de959bde4ed782b53c9b265cf77bf65e2e2699df50a45db8470c5ad523a73c04c2318c497d290b48a642481f8a78e90bfd8e4fbcac9ce3a010327"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "fluphenazine",
      "id": "16b0f4140c07b0b9c2d7e15796b0088250a69ce5979a76394c31c4736887b54e9190b99a67c90a9bec3e8d959f5588117119ceba1c4728ae43aded4e7f7d1d8e"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "geldanamycin",
      "id": "495a46f0ccb373f38cd5fc5172590ae53a0619efd473182ef38981d4f2d7d2e6631c171ef484aac26e3891e0d5ef27e716420629b6f3c62aed15ac224ad41430"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "methotrimeprazine",
      "id": "bbbb171bbd433b71632378fe1ab58c3b1ca98634e9047be609371bc2b1f61fcc560d954a1f23396ae85dae748dddaf326d6101b3575fc8e8f15023228523d278"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "radicicol",
      "id": "15ee26986060541275b04ff0d23cd5eaaeb7544dfe879b82097c282e7bf5ef0a9f71eb7104cd85f1f0019f7428965ce9b6cd2ecd2faa002aa5a214fe1833be48"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "sirolimus",
      "id": "102b031a00eed78fd9e5c4236defb90a8995463980f9060493bb5fd3159a3eb666cbb2b6a33a213c749a2b279ef6d149796b4f0b568e03b82eb5c89b0da77426"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "tanespimycin",
      "id": "409d39722f4d5c9457a215c12a920d2bf82d03e7f143571a2ce44293d3b8a741f96f61f35a43f0580f6588e3a11c62fc1888fcdc048311e8b3180dc20f703944"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "huntingtin aggregates",
      "id": "b002c83453fb9ff3e295ad07a36f9afee91ab00c52c321dee1b31e9b1ae80e79109adf64b9b235ba967d89545d80f66dbe86856bd4751018f2e0bf2c07ff477e"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Cellular Structures",
      "id": "62baaee5825138fe4a3dd5b9c757e91396a888844d473025c054a87d7694dd327ca74ef2365b83f072cd8a107630910f46590ffc68b7bf459833fe8ea40bb7d4"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Molecular Chaperones",
      "id": "cbd4d8183b7cd578b96afa148739bb4ae10720d38c4936bc957976341d71ff395011e8e37ffcd1b58bfee79d1fe5a0b7306d8c6555580cec4dcc22fa2949a56c"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Lysosomes",
      "id": "5bdc4f001303328428ac361a58c2c115c993a633bc703abff8f4f5a892f1674a1f4612a541e30ab897fb789fa8698fd11eac180236847f483cec9bc7ca9daa45"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "10521421",
      "id": "a8eaf0faa5eaf41eb32b825f303b657eb690df128f356ee74d94d293a654156b8b0314a15ee52c8fe172534ee43523d619e3012e71d61497ecc7c88a69b13370"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "1560402",
      "id": "2217f86ce31e5423d655f89888f91d17117a5861aafce36ea2f85e09b923cf82d88c2d975f3a571e6f981c79a5fb673f3057c79ae9db137cad7b3e88cdf15000"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "377503130",
      "id": "0c5be332d05561addbed95431647b6e3687d261a7b281115495a454fbb848132366e552f10b4d687ae3ed6eee778a97537e002e20627ca110e15cec1f247b5b7"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "675434",
      "id": "3445a70f2fec86b1ee954f9bdf09e6eb81b69b849dd43bf50707d9c795bea1d5ff475dda76a10a188b9e70aa3d11ba6d2c3b9e1a07d4d78a4a062e19a5e6ec05"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "799645",
      "id": "b1223361448acc2542be17f305955ac74f04032ad0a7df5d197e9e7138a556eb23a8cff6793994a06873888b074dde6cd2b386cebd38caca9956e5fd8e8d6bf5"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "877863",
      "id": "93e0bc5d24bc60e63eb38dfdea1d8fa22a7d9ed79c923da54effa48ff2491c5f424bb0fc4e7e60cdf5913ff47e487dd249c68b19126a6c69c1793fd60c6e390b"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "ATP metabolic process",
      "id": "6fa41f38953b19caed3b9495a93b66582242b79e5ad97c32d96cd971eefd925ee5866079bd60ed0d35fd62f092da34091555cbcb9ddfb3371026649547241370"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "apoptotic process",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "autophagosome assembly",
      "id": "c89c44d07abdeace0ea42e4bf8d32258af4c2a8d95d7b9c27cd0306d2efe69133503f24a6fd40784a4d845f7e0c1a6b0ff04bb029ae9a91dfc8ef483dd4f55c5"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "cell division",
      "id": "138e09942af5fc2acd4076eca7bd3a91b4d4efc84eb0fbb876a985b2e6a01d5d00b9771ed6b007402fb9cb61b1efccebc268d14458c7ece82e84c1696c7e61a6"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "intracellular transport",
      "id": "f356cfd4258ea10054d1fe208e3f6a1bcf3b4778065bc45839b76bd56d1177499d1d09ebb1a8241fd1e4801b51e2a4a287a8d0d04f7b25dc139e38f3cea94fbb"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "protein folding",
      "id": "3f283920a665a68c31087027b6be2cdb273deed17a908552364c1e9eb8400b4a849fe1aa46834cda0b7700391db3fe73a7603fc9b3336ee7aaf70deffee39189"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "response to misfolded protein",
      "id": "52a687039c53465c7fcaa59aa3f2fa116ea5a970f194811f26962e292357b7c7aff63c59c694070bd9bf2478bfa77b8dcca6ddce789397506c9109b1b5b5f155"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "autophagy",
      "id": "f1a3202be460e565f65c1445ee061e99f63cc05f9ab70c5d4d8d93ba180d6a94f65cb8d1ac6c5ba53c0a4d2e153db32135e6a0bffcfdfd4d84e6727594a70b0a"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "macroautophagy",
      "id": "568e5f70e05a1543c9a1d54019c461ab0802ff3556801ad06f2231e0687a80f2cbd21d12f808f5d72752f7cc8c484e0b32d830256321af323cfd08b1b63cc765"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HBP",
      "name": "Proteostasis",
      "id": "f9272dc303dc1a40e183bb77429a416f78ef2b95b207dfda09c188a5789b1cf6ffcae723cc4a6f351c915509c1e9e99ebc1daab87872ce60a6cb83b2122b39f3"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "HP",
      "name": "Neurodegeneration",
      "id": "96f5a3bbd33a722b2760c6448efdaabb70ed3e96434c786a9ad70ca7eb89b9585204c9e8df72a4ab1b5c7f617a36f919bde50523c31467d62a4842b479ddd805"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Endoplasmic Reticulum Stress",
      "id": "89273f58f970a9467557f020ba5f5af7f8eb84045d0b1fb2eeba697d56475fcb2dae9019025a1d89fab2cba9466474067ed76af341294164c040dcb7b6e90507"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Energy Metabolism",
      "id": "34ba674658457b3dbab614d7c94a9d15246c172e9111b7543b4c643547bd0c6a82222afa3f7da36ef3a10f79f530df4ad0c6d2d70e9be55151d16617e2568018"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Growth and Development",
      "id": "19bffd21f915c1806aeb512f3553d72b001a54f6eeb865a01622efbfaae4c524567cd8fb0e058a72657ed0851a02af2c462cd8f45efa39a34d363bff127ff01e"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Protein Biosynthesis",
      "id": "a1901823cdb2e3a674f5a2784cd1ba3c703ab26b2f9cc1687d95637882e85dd33d960b79161b6e160d0ec4cdfb663fe72aa214b36550f5b3952476ce40e141ad"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Stress, Physiological",
      "id": "dcb586ca715ba7eaa753d21a8456da0b8d63fb571f7e66f6fb21ef7e543af9415216c1a9afcbe10308f2845b35d64ee9d180f84ec2e439154136976b4d790291"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Aging",
      "id": "175e5d777b693461a2f6189ec21aa1f8324f054bc8acc641df82819a4c04776202053094a1c12915bdfd2244a6a5f639b7008b7f8e9a5ffea3c3b8aaa255d1b9"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Proteolysis",
      "id": "08f053829da37141585f38cef26f94f8bafbf2a652d28dbc4e952f33f072050ade09d03562130b4ee0ada625c0d484d2596c22c2d3a4bd1e5567fa9999c5df2a"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Molecular Chaperones",
          "id": "cbd4d8183b7cd578b96afa148739bb4ae10720d38c4936bc957976341d71ff395011e8e37ffcd1b58bfee79d1fe5a0b7306d8c6555580cec4dcc22fa2949a56c"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "HSF1",
          "id": "f14348a34dab846dcd69f4e44f9229a90bd3a44e5ddbcef4331d61dc959cb6e1aec7c1210063cb9d6f140de4ab55d0aa21cd9176aa9a75bd97939f364145b7b6"
        }
      ],
      "id": "bc59f2e91149f2137768f8ea956d9cdbe656720262e25a2c5bab90d504d06ef9292a16bc060367c5b323a9713a0be6a29e92a312b7434aba4296a24e3d0f546e"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "HSPA",
          "id": "c293d8f843520dae6cba835a86c0e958d54d4dad9658a8281d9540b21d8e39272f2548fe5c429cd97d5d9a3755643b8dc346c2aecf00d7d53ab3914574cbf62d"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "DNAJB1",
          "id": "34ef35309926dae000c9fe717ab665b294d3130de5a7c627cf49c030f267fa793f0903f6b011359bf5e33ceced49efec114bdd891dc1b45b0850aa3c00b7996b"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "HSPH1",
          "id": "36c67c1ca85967b0146e9447a9c41d71d942ad6468b32ae76033bafdc4254c47ea75642522d1f8a1d8c9c4f5c16fd899ad66848ace8d7f1af90aa366061346ae"
        }
      ],
      "id": "9f07d89f83bad049476a6f19b415cc6367f5d731453f93f165f3096fcae5c7ec6cec54fb942a1626043aa7f9e60eab5c8c94d39d61ff90a498d984271fdfde16"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "sirolimus",
          "id": "102b031a00eed78fd9e5c4236defb90a8995463980f9060493bb5fd3159a3eb666cbb2b6a33a213c749a2b279ef6d149796b4f0b568e03b82eb5c89b0da77426"
        },
        {
          "function": "Abundance",
          "namespace": "PUBCHEM",
          "name": "1560402",
          "id": "2217f86ce31e5423d655f89888f91d17117a5861aafce36ea2f85e09b923cf82d88c2d975f3a571e6f981c79a5fb673f3057c79ae9db137cad7b3e88cdf15000"
        }
      ],
      "id": "fecf1cf1c1fe92ce71728b13756774080a86f74fb9a73b26d4004297424a0882b4faf245a64329ab5e0388d3b4ae72569ffe2f27e998a16a683bdbc7e773d07f"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "sirolimus",
          "id": "102b031a00eed78fd9e5c4236defb90a8995463980f9060493bb5fd3159a3eb666cbb2b6a33a213c749a2b279ef6d149796b4f0b568e03b82eb5c89b0da77426"
        },
        {
          "function": "Abundance",
          "namespace": "PUBCHEM",
          "name": "799645",
          "id": "b1223361448acc2542be17f305955ac74f04032ad0a7df5d197e9e7138a556eb23a8cff6793994a06873888b074dde6cd2b386cebd38caca9956e5fd8e8d6bf5"
        }
      ],
      "id": "14e3237050d5d68f0410976763131f527f0d09478257ce2fbee16c3ec9de75be56c9592c6e3b07d7f929b7396ec3d03b1525e23c9cc0489f5b87e47c6564086c"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "sirolimus",
          "id": "102b031a00eed78fd9e5c4236defb90a8995463980f9060493bb5fd3159a3eb666cbb2b6a33a213c749a2b279ef6d149796b4f0b568e03b82eb5c89b0da77426"
        },
        {
          "function": "Abundance",
          "namespace": "PUBCHEM",
          "name": "877863",
          "id": "93e0bc5d24bc60e63eb38dfdea1d8fa22a7d9ed79c923da54effa48ff2491c5f424bb0fc4e7e60cdf5913ff47e487dd249c68b19126a6c69c1793fd60c6e390b"
        }
      ],
      "id": "6a5be5ce03b7d7fe6f789fe3639414821cb9633e55ca51e1f400d79e5ced2d4d21e535f22cd239036b85ecc64de9238995e8da9699a001210247c115ee2e5da1"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "CCT_complex",
      "id": "554e7f9c82615ea7fa9719f442dcfbb91f532f63193db585c9b528504f6d0ba8836cbe52a868fd724dbbc796b40a4ef47db1e28e8419c0a06f995ab05e11bb72"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "AKT",
      "id": "3263678a1e320013081e7134e7e64e91b2c66e6fbd10dd7fe4fd282cf0cc3ba29b5cacb5e8eb0a8ac0a194f73b80dabcea5465b0fec5b044290b259ba889cef1"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "HSP90",
      "id": "a5bdfe1366faea602e03fefece5805427ae4af29a007d93291e6224dc74a8cab597169f580be49b50b4c24e83fa743fefa44549edb827a4dd531224d7d373245"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "HSPA",
      "id": "c293d8f843520dae6cba835a86c0e958d54d4dad9658a8281d9540b21d8e39272f2548fe5c429cd97d5d9a3755643b8dc346c2aecf00d7d53ab3914574cbf62d"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "HSPB",
      "id": "fd98dc50f6da0fc63d105440679adf158811af92c96e5c774ac44e2ec5575f1134fbede9eeaf90f18ca92639bd4edd6ed8201907120479aceb23983d94550a3c"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "Proteasome",
      "id": "645bfb1e8fc6c1ec119c660999773cfddcb4cf0f2f8f8c0e07af96aceec91f6e5218098423451401e3da7ba628a36a7437a426ca75f5ca004f97d56d7bbfd541"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "mTORC1",
      "id": "a1c299171aad616f24329a91ca82660e0205dc2da1b10758111e4a1dfc283c68f49134e8b0987b93bcaa6c92fceb45567212a78013bae1639af5468de9caa508"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "N-terminal fragment of ATF6",
      "id": "9f74ceb3a053a604f988a0278dba4239ba428fb4095db606f91135eed36b614974209c6a79e2f3b4b7e789df51dde6a97c7a59c78206cfd0da45ca5e4fa51f1e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ATF4",
      "id": "39a285ddc452b4f28e91e623542bb42630a04fa984f8d8d08b21fe9a9f250f9005e484bda93c6768a0559ed58a12cd4bb6b8a9aa26b52d40e87ad7e32014c892"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ATF6",
      "id": "02005095fad6ae7046bd0ced10c2a62d67c5884f2ed8b5abee65e06a064dfbf90d82788e40a9f9649a4750294d8cfcc6d51df20195561236834bfb6c9d40fc1f"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ATXN1",
      "id": "afd2ab5f00b85d7132d3c65b8d64ec5db7d08f6977ae334d9de4658c80afed502ca4c661d9f487e71d5c3df5e1c8da1c883d65990d10d96a5c6d25b259bd47f3"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ATXN1",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "?"
        }
      ],
      "id": "c589a4363cb192e1c63e11ff974464a32b426bf45efd3330dcf8f363cb32f7c16d0fc079ded877ed04acbc9228376535e818527dacc6a162810a3b6aa1078c3d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ATXN3",
      "id": "c6102d230a5c67109dd4fd3cfaa57f2745158769d72caa5add04724e9dfe725c935bb1ec09338262f4184baa34fb990c7287982726308939a7f9e77987c33b64"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "DDIT3",
      "id": "3acf87bfc0e8d3ada59e5f78159de0b3f2b012ecf9dc2f9164bcde3ffc6ee39f456ef190568754de2996d20aaed3c86decd20f4265ca0822b428d6891c5051d6"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "DNAJB1",
      "id": "34ef35309926dae000c9fe717ab665b294d3130de5a7c627cf49c030f267fa793f0903f6b011359bf5e33ceced49efec114bdd891dc1b45b0850aa3c00b7996b"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "EIF2AK3",
      "id": "79755b26d8d0165aea6a2d926c2f0e994f02842441b9de19e3fa33f208ddca335adf10c82387bbd996edc0c62c6abee805d2926feaaeef1805a82e9b18549c8d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "EIF2S1",
      "id": "f9f140f1e21ce20744dd2f47644091ad5633013e7317059002f401ef9513a8cfed5a639c3a0691e4f1526d1c3c13134a521220f101ca7dfb1c34ea87c7e7f5f5"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "EIF2S1",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "dd2b7c0fde0e07632f2d51f640cc4853b0f0ab2570ecde21bbc5804e7772ff30315d2906e1633e1d6ecef7ca291d854b58846ed5c671e9f4854db9601c69e5dc"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ERN1",
      "id": "dfd405ea7a10f70de7646eb6c22fe0b9bee8906dbe1fc6d7e93399bfda46456ce70c846f404ef8bf13772d120bac608a9a63bdd25ea5b1f75aecfef326359fdd"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ERN1",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "912aeb3c848c985fa943a6ad3df838baf5db603f4dd738ff9919c76f01ac596cdca07bbb96dce2953b71c740137401943726e6cb7f52fa7487fee6231c82e0e3"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSF1",
      "id": "f14348a34dab846dcd69f4e44f9229a90bd3a44e5ddbcef4331d61dc959cb6e1aec7c1210063cb9d6f140de4ab55d0aa21cd9176aa9a75bd97939f364145b7b6"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSF1",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ac"
          }
        }
      ],
      "id": "5778647ddfabf74e0ac880e56368797c159fe2399a47a1aa3168128a53a975a836248a195f7b41f956aae94789b1159f228ffb2abe07441f28260f6ada6cfd14"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSPA1A",
      "id": "fb0cbb9cc4e216ea41397bd2965faa82f855f844ecde6a1f971a7a3c7ae9e2f1bb20285815aaa4963ab45dee6b4452cdb3427c3b6f4c1f05a16ea3ea8fb299e4"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSPA1B",
      "id": "45c3aeb824afad6e9d5a7d4f29cbcad07f40a16edd7c576f25128c024d40f26f582a414fe10f59ca75d82c01da967deef47e11e006b3435a33da28c55b262dc1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSPD1",
      "id": "f0cac6ac9384c14aafe44f9bb58139b1d3326cbc9b523d94eba4bba2580c2b9d83f8c85858c115d4f8e333e0fe1ef75672140e493b799c42ed18c18b3132b607"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSPH1",
      "id": "36c67c1ca85967b0146e9447a9c41d71d942ad6468b32ae76033bafdc4254c47ea75642522d1f8a1d8c9c4f5c16fd899ad66848ace8d7f1af90aa366061346ae"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HTT",
      "id": "f3dac0d39a258f730f45800014166f0cd6e8002b0bd1f9be6aefa0958d84dc3a67a48721743405568d2c7942ea831f7bdc6cdcc7a990bb1a7d5161351e6e67b0"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HTT",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "?"
        }
      ],
      "id": "ecfea6b35e9ef56154b1f7d1255c3ae63e48c14c262428a01170245d2ffae3786b0b2439c3b2b1f6abf506d5ff2a338d6de2d7a2c18ee7defc89d51c50e22f75"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAP1LC3A",
      "id": "696720fe445fd05f8ee69df577c1eb30a03353ea55fa2d483f9b533222cccec6a8edb971af1b1296bd3514c9546a59e158162797ceb5d4ef8937bfee4600a06d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PRSS1",
      "id": "51326c17210ee5623daad9dc74f90f509efb2d484be55c7125a76c9589d63726a3f3569c6b8cb5f0b8df8388a1fedcce177b324f7a0c34320365140ad7f79025"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PRSS2",
      "id": "30c69c378d408b414214014a00863036dab86ac12ac2c34af14bf2fcdc6f37fdde31239348b864cd1a31f868b57a75c53357b6c055807a4f1a5c3403511bd29e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "RAB1A",
      "id": "54bc7323fecdeb3ec17a7ec03afcdf2c5746c72017167baa729f2a3fd192fd4d3c54bd306b2c5e3927627015703e9462b366500a051476951b8b0a24f353bb8d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Ala53Thr"
        }
      ],
      "id": "d2068443e7a690d5d02ecf646516124d655e615c8f4a7c320cad114af8b6cb752bcdb98e8973c053690af90c8cb72d8d4211d4f8f1314c79c1aab0bbd385c692"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SOD1",
      "id": "7bebe84ddc870a4ceb70828bba41ec797b861126138342942eb8124edaef94657501d4b9c4a69876b38e0fba2ff4cd5a91b560173b73723f03809ed503e90e98"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SOD1",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Gly576Arg"
        }
      ],
      "id": "4df730644bf87ce6066f6095009edaf876cb2b496a7d98d0329660e5540ef6563a2294072460f3fac143b7a8f613345cfab45c95d2f92f78382824bb00efd725"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SQSTM1",
      "id": "8cd06d93cab875a139eae92082f11af5ad651146fabba6fa298a46f2cfda5bcb2bccf9dec8cc73067f5c11595d8eeb288f5c13f6a56dd316b54d108e5e66217d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "TARDBP",
      "id": "96048ed5d196081ca480607e30326cb8bb474db3177bfdeea242002c3c7a4681b51247acdfdd0a3ae600face27455ed0e62e9c750e79b240b8e7418150b92963"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "USP14",
      "id": "1470a3d143a2fd5929b833f4f8c5e0881731040826296bfe6062bd3ff1474e282150885ab09707960d7a54489ed5c13cf8251602f437c10c26dc5b0ca583a960"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "XBP1",
      "id": "c6315ce7cf274cdf7ff9a7203c63315210438a553ae637a8c29c2abaaeadc1fa19c9ca275ad8f53d1c477bb7a6e32d7ebf6adb5697bdf8fddb3ac75763fb1e32"
    },
    {
      "function": "Protein",
      "namespace": "HGNCGENEFAMILY",
      "name": "DNAJ (HSP40) heat shock proteins",
      "id": "6b6e0265cfbceaf9d409a1ffd96579c8cf4b416cab3a7aece4f92367c30680a273b1bf48525b5ababcbc7cdaf7b1e1c5b6c718b3136302cc3ee2f3a958513b30"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Atg5",
      "id": "b4abaf591febabfd6f99de67fca10e3afe7102f474b7990b6d58949aed0d271f5cecfb3c9ff86f34dcc6166755ed2d92d65ccda35b52bc6e200549fc489c799a"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Atg7",
      "id": "b2cd1052f916403510ac11216f8d12a33c39a52173383dab19cd7f6e10a79bcae34f35d742900f9e8fb47ab1ec4e0679020ae68f2f4529ea437d6351469cdcaf"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Alzheimer Disease",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Amyotrophic Lateral Sclerosis",
      "id": "5e56d7b5172af0ae281c2f920b132d7b2263ae5eff7b0f1c9a22347914d8c169c79314aa7738c7e68cf75fac198de894bff58cb9fd4a0cb95ab434310fa07daa"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Huntington Disease",
      "id": "1879e0f73bb6f3f680c5793e5c3b9370792a52545c46d4ee9f41a8ef46edd5ba61400e77effb39bd0d1e7f3de6470e091c5d8e6c5beed8d780456b6740a4406c"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Machado-Joseph Disease",
      "id": "1126e0e3692d883e887717636efded5f25f740e87011b2aa0236bafcff5671c45b67830c45a8a61a567b9d502477276667c7adffb1194b0cb0914b9eb7c44138"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Neurodegenerative Diseases",
      "id": "95863a6d11beb3bd993523e1c8c7e210d281b0c092553f6a4cf27dd3ecf2fa51b49c5056b8aed6f7ac7c82f99101c34bc9fc0afc3dce117fe011d159ba9e4c89"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Parkinson Disease",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Protein Aggregation, Pathological",
      "id": "46c415842841b034fc97a69dd54cb4357bd60585802d3f9e8f1a48802ce28b882da2260272dee02c592a7f90e8fb3dc722187e0e301491eb30ee5b803305a65a"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Neoplasms",
      "id": "3acf430fb763193b79a4e43ffc2cbe0822fcb8cb68c26ff93e614c1d6a7dc63fd8afca2116db60243419623d330c5085b60e421eccd5406ac8edf17d2340b500"
    }
  ],
  "links": [
    {
      "line": 84,
      "relation": "association",
      "evidence": "Proteome fidelity is maintained by the protein homeostasis (proteostasis) network (PN), a multi-compartmental system that coordinatesprotein synthesis, folding, disaggregation, and degradation (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 28,
      "target": 33,
      "key": "0dc6b0bf09f35cfbc4fbe22ebb2756296f0d0ea301ba01971888c7a1d5004857e9729289e9697ff440b0003042170d9b6805cbe4933fecca3dc68bcbd053cc12"
    },
    {
      "line": 85,
      "relation": "association",
      "evidence": "Proteome fidelity is maintained by the protein homeostasis (proteostasis) network (PN), a multi-compartmental system that coordinatesprotein synthesis, folding, disaggregation, and degradation (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 28,
      "target": 24,
      "key": "15bf1b3254a4f48876d957249e4a3b5f5df10702de2f1f468876045365373ce13af15b5ba21317b51922da8d19f8be112f37b8755d225bc69c105105a0bcdc03"
    },
    {
      "line": 86,
      "relation": "association",
      "evidence": "Proteome fidelity is maintained by the protein homeostasis (proteostasis) network (PN), a multi-compartmental system that coordinatesprotein synthesis, folding, disaggregation, and degradation (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 28,
      "target": 92,
      "key": "1cc2206feaeb83ee2563d981b4888d7d4d9d5090a03450385d9ced3a9aff1664609c305813c088a065553c4668c3a946c316d7e04233351951e40930aa1a9123"
    },
    {
      "line": 87,
      "relation": "association",
      "evidence": "Proteome fidelity is maintained by the protein homeostasis (proteostasis) network (PN), a multi-compartmental system that coordinatesprotein synthesis, folding, disaggregation, and degradation (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 28,
      "target": 36,
      "key": "6b738c14555190f0f6b42a559cbded50a6fa715f0f995c279cf7bdc68fd1cac4a10b3734714521b4c61b86d56ce9fe67bc46db759753b9c79d4873227ffd5c09"
    },
    {
      "line": 329,
      "relation": "decreases",
      "evidence": "As such, it is feasible that any reduction in the protein degradation capacity of a cell could contribute to proteostasis collapse and promote aging.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 28,
      "target": 35,
      "key": "a2e905621e2cbc5a7988acaa894cca3a4c4b4ab2e9acd01df74408177b5379871c1cfef2001907328612b958918d47f7765eb274824de26fcbe8d4f50720a189"
    },
    {
      "line": 84,
      "relation": "association",
      "evidence": "Proteome fidelity is maintained by the protein homeostasis (proteostasis) network (PN), a multi-compartmental system that coordinatesprotein synthesis, folding, disaggregation, and degradation (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 33,
      "target": 28,
      "key": "de4c1f4586a300e7d66c4ef611e1073b133da945fea7c9647aaa23cf408eb9056127582be21e09fc609856ba8300f52165011aa8103352be0f9ca3511f85af86"
    },
    {
      "line": 85,
      "relation": "association",
      "evidence": "Proteome fidelity is maintained by the protein homeostasis (proteostasis) network (PN), a multi-compartmental system that coordinatesprotein synthesis, folding, disaggregation, and degradation (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 24,
      "target": 28,
      "key": "06ca84e0c9005f672d726671ac51908c9363099d804795cd2235244e005b9abf3949dcf9ff1c9f10fa8cb5a0ff83092999cb502bc27e1e3fe9b065e1db7888e6"
    },
    {
      "line": 86,
      "relation": "association",
      "evidence": "Proteome fidelity is maintained by the protein homeostasis (proteostasis) network (PN), a multi-compartmental system that coordinatesprotein synthesis, folding, disaggregation, and degradation (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 92,
      "target": 28,
      "key": "6e954fe007e8979f122bb0ab5999532d46c5525346ad1174fc6509bae088344df488d6d2eb761ace5e6a025fdc5196759fdcf33e33f49fd20add63eed357a3e2"
    },
    {
      "line": 237,
      "relation": "association",
      "evidence": "Protein aggregation is recognized as a hallmark of neurodegenerative disease by the consistent appearance of detergent-insoluble inclusions and aggregates in the nucleus and cytoplasm of neurons.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "CellStructure": {
          "Cytoplasm": true,
          "Cell Nucleus": true
        }
      },
      "source": 92,
      "target": 90,
      "key": "bb193a898581da4e0fd237382faa61597da34a7a6b74489bd323c4a7fb23366a67fb58c0942b97a2bee1cc776187f22cc1b8f66e9fb9646543a8583a9c50393d"
    },
    {
      "line": 244,
      "relation": "negativeCorrelation",
      "evidence": "Studies of chaperone levels in tissue culture and mouse models of polyQ disease showed that the levels of HSP70 (HSPA1A/B) and DNAJ/HSP40 (DNAJB1), as well as some cochaperones, decline with protein aggregation (64, 65).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 92,
      "target": 64,
      "key": "12da8b3cf24d9fbd7ba368c073458873f7636c13e26efac0d592121a8b4c42601bddbbb34a542a27d2e40ed81b75322a86bac493fe1b4252df5327cf44613b5d"
    },
    {
      "line": 245,
      "relation": "negativeCorrelation",
      "evidence": "Studies of chaperone levels in tissue culture and mouse models of polyQ disease showed that the levels of HSP70 (HSPA1A/B) and DNAJ/HSP40 (DNAJB1), as well as some cochaperones, decline with protein aggregation (64, 65).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 92,
      "target": 65,
      "key": "d01235a6990719322e0b1ae1db5bff5c930fb188bebcae4b4c4ffd086124bd042c5d2f5830c480202aff51da9e9219c0653a19a00e80e72773eac2f2411496e5"
    },
    {
      "line": 246,
      "relation": "negativeCorrelation",
      "evidence": "Studies of chaperone levels in tissue culture and mouse models of polyQ disease showed that the levels of HSP70 (HSPA1A/B) and DNAJ/HSP40 (DNAJB1), as well as some cochaperones, decline with protein aggregation (64, 65).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 92,
      "target": 56,
      "key": "6612e181fd95e801487fdb04d52145b4bd8e0a42a8fc817d04f8e228861dd4960793e580d2a02fe4075d98a79eb2a3ca4d3a5ed404ba356dc3be3161d9a9ec5b"
    },
    {
      "line": 87,
      "relation": "association",
      "evidence": "Proteome fidelity is maintained by the protein homeostasis (proteostasis) network (PN), a multi-compartmental system that coordinatesprotein synthesis, folding, disaggregation, and degradation (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 36,
      "target": 28,
      "key": "48be401861f90fb65a9ba55202052896dc684f23f987da0919d32307681af2c7765aaa943d13bc4ac453f48eb64df06c8a8b1f6dc7930dc7441f6919e3ea5e61"
    },
    {
      "line": 92,
      "relation": "regulates",
      "evidence": " Furthermore, the activity of the PN can be altered permanently or transiently by development and aging, alterations in physiology, or exposure to environmental stress (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 32,
      "target": 28,
      "key": "4953a507711281ac41396666204d74c8edd2f4797bbb8e98965534779660ce1702455ad4dfcbbb13ba2a08c4eacd4f21eb8d56b06671589b16c13de8c000a476"
    },
    {
      "line": 93,
      "relation": "regulates",
      "evidence": " Furthermore, the activity of the PN can be altered permanently or transiently by development and aging, alterations in physiology, or exposure to environmental stress (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 35,
      "target": 28,
      "key": "467da8ad5e7a27aa808bb09249e830a29060df4e751a9d868b542e5755a9a8124cce770facc10e85c384769bb181923c7768ed75de1b67b3b129902991425608"
    },
    {
      "line": 315,
      "relation": "decreases",
      "evidence": "Additionally, an investigation of chaperone and cochaperone gene expression in young (36±4 years of age) and aged (73 ±4 years of age) human brain tissue revealed that of 332 genes examined, 101 are significantly repressed with age, including HSP70, HSP40, HSP90, and TRiC genes (113). Furthermore, 62 chaperone genes, including several small HSPs, were found to be significantly induced, likely as a result of the cellular response to accumulating protein damage with age (113).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 35,
      "target": 45,
      "key": "d03eeb670a1fd169ab30c267966a4bfbae46b09b5f69de579dcc599bb4581ecd0064b207a232ed70952f1887db2765fd5bdc660b04b050e74ba5999124bfd313"
    },
    {
      "line": 316,
      "relation": "decreases",
      "evidence": "Additionally, an investigation of chaperone and cochaperone gene expression in young (36±4 years of age) and aged (73 ±4 years of age) human brain tissue revealed that of 332 genes examined, 101 are significantly repressed with age, including HSP70, HSP40, HSP90, and TRiC genes (113). Furthermore, 62 chaperone genes, including several small HSPs, were found to be significantly induced, likely as a result of the cellular response to accumulating protein damage with age (113).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 35,
      "target": 44,
      "key": "d478cb7b2c9a695b62d7f610bc9489d7c05dc4f9ddab6073993bc20e80f22fa69f97df9e55c9e940ecd76340ff8f8cbdf7eceb71034768a98d2f57294f2f7ad9"
    },
    {
      "line": 317,
      "relation": "decreases",
      "evidence": "Additionally, an investigation of chaperone and cochaperone gene expression in young (36±4 years of age) and aged (73 ±4 years of age) human brain tissue revealed that of 332 genes examined, 101 are significantly repressed with age, including HSP70, HSP40, HSP90, and TRiC genes (113). Furthermore, 62 chaperone genes, including several small HSPs, were found to be significantly induced, likely as a result of the cellular response to accumulating protein damage with age (113).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 35,
      "target": 83,
      "key": "9cea6c5f2b08d8f92eccf9a143036be2d85bb8e88f38b7d9ace0bb2bf3cf1349c10357374bb80454669f66d49aa620f20e79dfb0356d55cbe3ce5c08b4c18f8a"
    },
    {
      "line": 318,
      "relation": "increases",
      "evidence": "Additionally, an investigation of chaperone and cochaperone gene expression in young (36±4 years of age) and aged (73 ±4 years of age) human brain tissue revealed that of 332 genes examined, 101 are significantly repressed with age, including HSP70, HSP40, HSP90, and TRiC genes (113). Furthermore, 62 chaperone genes, including several small HSPs, were found to be significantly induced, likely as a result of the cellular response to accumulating protein damage with age (113).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 35,
      "target": 46,
      "key": "ad38cfb43a22b54516bde3c30925ee281181b426202aec6a7fa0bf0825e479d420e827b1dba46c65ed563840cff15c56b34f1b6a2dc42c6e44c812d5835cdc21"
    },
    {
      "line": 94,
      "relation": "regulates",
      "evidence": " Furthermore, the activity of the PN can be altered permanently or transiently by development and aging, alterations in physiology, or exposure to environmental stress (1).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 34,
      "target": 28,
      "key": "9eb856115814f16a9358916a9ff4f75c82aa2389c20f123ee3676ebd628ff6bd7425e651c233c808fedf019d231bb6ebede5d82b48bec1aace79d64aba61bbc6"
    },
    {
      "line": 99,
      "relation": "isA",
      "evidence": "Molecular chaperones are central to the function of the PN and can be broadly grouped into the HSP70, HSP90, DNAJ/HSP40, chaperonin/HSP60, and small HSP (sHSP) families (10, 11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 45,
      "target": 11,
      "key": "851c8774c01ed2831e3b8655c5c4de286606cf349178beed0db574d9235b9c0f6f90197bc07eae042471c7596a178eef09ffd2085d1d0a3c2c2138825fed06a3"
    },
    {
      "line": 112,
      "relation": "regulates",
      "evidence": " As such, HSP70 and HSP90 are central to the process of triaging proteins for refolding or elimination.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 45,
      "target": 24,
      "key": "3e8efd73e8b6ef94f564e0d554217689bad28e08953a1ec0e3e7c46b6ef177023b4494f34698e87a85916e4cba1e0e9cb0424b9a4d4f360b769fcd1417ba5cee"
    },
    {
      "line": 113,
      "relation": "regulates",
      "evidence": " As such, HSP70 and HSP90 are central to the process of triaging proteins for refolding or elimination.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 45,
      "target": 36,
      "key": "b785457927f73987fad05fa72da972014e05d47ba9fa64ecc4a7728cb227408e6b59c5b3d46ece70e8b62e932fcbf23ec43ae8d3330d8f530324da087a162f67"
    },
    {
      "line": 229,
      "relation": "positiveCorrelation",
      "evidence": "Furthermore, increased levels of HSP70 were found in the cerebellar cortex of human HD brain samples but not in tissue from unaffected individuals or from brains of PD patients (57).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 45,
      "target": 88,
      "key": "fd64f0805601ba80bd0d71813383b543b7686ac4782e13c7121b927444223db770594736ea4670380e14f5e8b6524b6a23758be9917ce5136318098d157f5fdd"
    },
    {
      "line": 146,
      "relation": "decreases",
      "evidence": " As discussed above, one approach is to employ specialized molecular chaperone machines to release misfolded proteins from aggregates and direct them to the proteasome for degradation (19).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 11,
      "target": 92,
      "key": "af21ff9b35592d9b41e465be8447762af4b5ea81bed6e511cace34866a7013f56924727f28f64aa3fb93cab71d9819d5d962079789d1950364e68561330475f3"
    },
    {
      "line": 100,
      "relation": "isA",
      "evidence": "Molecular chaperones are central to the function of the PN and can be broadly grouped into the HSP70, HSP90, DNAJ/HSP40, chaperonin/HSP60, and small HSP (sHSP) families (10, 11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 44,
      "target": 11,
      "key": "0568fe2ff61c8accd758891078ea2bdeb5214cbd049eeb932bb0198224f48caf34b8407c9324b6c1e8677152b080ea08e45c66abb6ef2c33f83e329d86d6f7b3"
    },
    {
      "line": 114,
      "relation": "regulates",
      "evidence": " As such, HSP70 and HSP90 are central to the process of triaging proteins for refolding or elimination.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 44,
      "target": 24,
      "key": "9d0448cbcbece6dd98fb1a93cac966e9f34ee799f934a6360620dbd181320b140dfb8f9619059ab6f85bfac1dc79e7b31007828974400b8307c97bfceec9debe"
    },
    {
      "line": 115,
      "relation": "regulates",
      "evidence": " As such, HSP70 and HSP90 are central to the process of triaging proteins for refolding or elimination.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 44,
      "target": 36,
      "key": "1daeeea7ec8f3b23fa8814014af5233408556a60e097e461ea5e66b5c59a3faa27f17d49c422fb05a2153988bb6fec639765abda2d8eb57353b42677352393e7"
    },
    {
      "line": 336,
      "relation": "decreases",
      "evidence": "One strategy is to directly activate HSF1, thereby increasing the expression of multiple molecular chaperones simultaneously. This approach has been traditionally achieved by inhibition of HSP90 with compounds that bind the N-terminal ATP-binding pocket, such as radicicol, geldanamycin, or 17-AAG (64, 132–134). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 44,
      "target": 62,
      "key": "d038c69f6e6fc34e178e553cdbb4a01973b7dc4dfa10d3b9d1ac8502ff5221e446852c96b9087e6abfb92796be9ae1f80800c99d87b071bfee163a5d35ea5091"
    },
    {
      "line": 101,
      "relation": "isA",
      "evidence": "Molecular chaperones are central to the function of the PN and can be broadly grouped into the HSP70, HSP90, DNAJ/HSP40, chaperonin/HSP60, and small HSP (sHSP) families (10, 11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 83,
      "target": 11,
      "key": "9c1c1a35e9ed2731f45c4034f548db3fe2f49164fbf1bca19a9842e87ff7530e864bb4565dc4e632bf5b33a139e99b2aae992a6f10633cf973a38c2abd79ecc7"
    },
    {
      "line": 102,
      "relation": "isA",
      "evidence": "Molecular chaperones are central to the function of the PN and can be broadly grouped into the HSP70, HSP90, DNAJ/HSP40, chaperonin/HSP60, and small HSP (sHSP) families (10, 11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 66,
      "target": 11,
      "key": "d0a6f0180426b905549946a303324277c36d142714851547b7b7c52a6d8b2277e8b7f6a72df4baeddfaee63be33cedf6c6ebc70d90520080a6f02d609cece147"
    },
    {
      "line": 126,
      "relation": "increases",
      "evidence": " HSP60 is essential for maturation and maintenance of the mitochondrial proteome and is therefore intimately linked to energy production.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Mitochondria": true
        }
      },
      "source": 66,
      "target": 28,
      "key": "c2603fa4245c9166d1e077bd79cb680dba594a62572f055c4eced76e5c4da7c77dd730ab5b3278fa1d61abfcd109135276600b9711af645a78473ba853778812"
    },
    {
      "line": 127,
      "relation": "association",
      "evidence": " HSP60 is essential for maturation and maintenance of the mitochondrial proteome and is therefore intimately linked to energy production.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Mitochondria": true
        }
      },
      "source": 66,
      "target": 31,
      "key": "013a36db042a1285aa8758480491d47992fe53e36cd84bd790c5583011549f54273c881e0820a5a594086643bdb51941c86d2fc5bfcd4eb470c5ad9d8808d635"
    },
    {
      "line": 103,
      "relation": "isA",
      "evidence": "Molecular chaperones are central to the function of the PN and can be broadly grouped into the HSP70, HSP90, DNAJ/HSP40, chaperonin/HSP60, and small HSP (sHSP) families (10, 11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 46,
      "target": 11,
      "key": "b9c9751bbb36844dd23775f55ba95b248fd903eb094588616a874335e9cecc0614bc5a7e159a2b57ea9f18e729fe9d4d0fbb4bec793b3139f4f997c3dd005da3"
    },
    {
      "line": 107,
      "relation": "increases",
      "evidence": "ATP hydrolysisis essential for the chaperone activity of HSP70 and HSP90, causing conformational changes that result in substrate binding (11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 19,
      "target": 45,
      "key": "7b3d8e217c4eeea6ecc0533940beaf1fe9bd480c12c52bc84e1e4897cb5a3da891aecc978174b5395beeb5bb9ba0ee53d9b0d9dc92e54ac6b4cb1102456f7be1"
    },
    {
      "line": 108,
      "relation": "increases",
      "evidence": "ATP hydrolysisis essential for the chaperone activity of HSP70 and HSP90, causing conformational changes that result in substrate binding (11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 19,
      "target": 44,
      "key": "a5fb2c9d464593506531e1b0771735259e97212ea1d65c1f19a0f0f436843e849e038d5197c2d23e5565e595dd27fcbb90ff2e506d4a144756468bf250b6a75c"
    },
    {
      "relation": "hasComponent",
      "source": 38,
      "target": 45,
      "key": "1fa5a2aa4307a93aecf5eb6c7799330a5449ccca43e139a5e7994e4c9d109e3bf8309b0ceb7df50c2b649cbe7f54a3657ae6392dd7c2decfce5d76295edf04f7"
    },
    {
      "relation": "hasComponent",
      "source": 38,
      "target": 56,
      "key": "0691a8dec409ce22f615e530f3057743679b6f1f4b27ea40eee50321215525cd65fcb49f1e458d8f1332adb1c570ab18cf12b09a725c4a3f12ae6fa7d95dc3c6"
    },
    {
      "relation": "hasComponent",
      "source": 38,
      "target": 67,
      "key": "1650e7e9a8c8e8fd67e0414f21b6538ad53887fb10e9fd9b3d99f0989b9caf53b527274d03a1040bb8045eccdacd1c19a4b74f6dde53f6aa0fea718d2e305204"
    },
    {
      "line": 121,
      "relation": "decreases",
      "evidence": " Perhaps the most significant example of this process is that the HSP110 molecular chaperone, long considered simply a NEF, can catalyze protein disaggregation as part of a complex containing HSP70 and DNAJ/HSP40 (18).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 38,
      "target": 92,
      "key": "4cad027b7238c3396b5c1984574005b7214b5509f951d0641a2182c8fa893d13b6475386705db88efad6d5db804538c6173f91f1926882033e0e60edc94a12a7"
    },
    {
      "line": 246,
      "relation": "negativeCorrelation",
      "evidence": "Studies of chaperone levels in tissue culture and mouse models of polyQ disease showed that the levels of HSP70 (HSPA1A/B) and DNAJ/HSP40 (DNAJB1), as well as some cochaperones, decline with protein aggregation (64, 65).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 56,
      "target": 92,
      "key": "fa0476a148e836aeb09a37bbc74835c6d038ea3b7f9eedba91518cabe7037456e3011d6158277e74fac671b33d1e78acdc0b431117521a53ef45dc99e5dc6680"
    },
    {
      "line": 127,
      "relation": "association",
      "evidence": " HSP60 is essential for maturation and maintenance of the mitochondrial proteome and is therefore intimately linked to energy production.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Mitochondria": true
        }
      },
      "source": 31,
      "target": 66,
      "key": "7f23d6973ab47d7f69fe5337f052aa85dae4a51b8fa77a4230e41e15ff41f7fcf413364656fa965dbbea7344130f86cbe872e0a8a7c9206ebaef96817ef63e93"
    },
    {
      "line": 133,
      "relation": "association",
      "evidence": " TRiC is essential for proper posttranslational folding of the cytoskeletal components actin and tubulin and is therefore essential for cell structure, division, and cargo delivery (11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 42,
      "target": 10,
      "key": "c7c81abb3f5513941e4b1aa48950a8a48028f40cc8444e2eb7dbff6c6f9c3962c5bc4e56435990652c44ce7c91df3aa9c9904a21549efa55400d5c2a24fdc904"
    },
    {
      "line": 134,
      "relation": "association",
      "evidence": " TRiC is essential for proper posttranslational folding of the cytoskeletal components actin and tubulin and is therefore essential for cell structure, division, and cargo delivery (11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 42,
      "target": 22,
      "key": "fcfd568bcacefbf0591a9fa1794c5c5fd5c6501ae3cbbd4d4e4d6a7654833f8d2a28c4dc99baa3baa68540dd7b458ac5351ccd1bdd414ea41d6554b1bc6833a9"
    },
    {
      "line": 135,
      "relation": "association",
      "evidence": " TRiC is essential for proper posttranslational folding of the cytoskeletal components actin and tubulin and is therefore essential for cell structure, division, and cargo delivery (11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 42,
      "target": 23,
      "key": "c00060f815267532b7bf811b7a55f2d45f30318e81cc173faca0777fd20c453dc107b1fa95ee08c6278e37d93ed564202eccf0829f301d29cdece149297fc0fb"
    },
    {
      "line": 350,
      "relation": "decreases",
      "evidence": "HSF1A suppresses toxicity in cell and tissue culture models of HD and SCA-3/MJD and appears to activate HSF1 by impairing the activity of TRiC, a recently discovered negative regulator of HSF1.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 42,
      "target": 62,
      "key": "a9a44cf30b4b3e911a50c9f697cb391a96be66b59589c3750beb27fac2a117819996eb8daf10b9915c748d9fcfca6ab60772e0bd850ba214947b792b962d9abd"
    },
    {
      "line": 133,
      "relation": "association",
      "evidence": " TRiC is essential for proper posttranslational folding of the cytoskeletal components actin and tubulin and is therefore essential for cell structure, division, and cargo delivery (11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 10,
      "target": 42,
      "key": "49e016e6b28d34b5fdcda1712f06dd242ceffa5d933fa77c71ca37f6b606f270ad9ae4ccdce6086a9f0e336bfd5dd52bb42dcd048b4f561f0b4e7dc85e3c6a21"
    },
    {
      "line": 134,
      "relation": "association",
      "evidence": " TRiC is essential for proper posttranslational folding of the cytoskeletal components actin and tubulin and is therefore essential for cell structure, division, and cargo delivery (11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 22,
      "target": 42,
      "key": "01ad65ed81b457aac391ce6dda421d5d5f6474fca54d99bd7be133dcc40111b3a254cf2aac41f244bc4e17f4303f00d3323c617b9382e5e116817918afe06eba"
    },
    {
      "line": 135,
      "relation": "association",
      "evidence": " TRiC is essential for proper posttranslational folding of the cytoskeletal components actin and tubulin and is therefore essential for cell structure, division, and cargo delivery (11).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 23,
      "target": 42,
      "key": "9e543cc3e6678709837c7d7d69a60e9991e5714e5a81c4c28c43cde07279d9c1d8002d007e5c551560e61a3ac6a97f7023b62145e51f5581036810b1dd58e8db"
    },
    {
      "line": 140,
      "relation": "increases",
      "evidence": ". Proteins can be degraded either individually or en masse by proteasomes (20) or lysosomes (21), respectively. ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 47,
      "target": 36,
      "key": "917a2a508597dd892389b3acbadb23cdf8098d0b0a9883d699b5466026e2e87de57153a7acea1d8d3ec80477dd5dc873db46398d052c1616d5f64bf987f17603"
    },
    {
      "line": 147,
      "relation": "decreases",
      "evidence": " As discussed above, one approach is to employ specialized molecular chaperone machines to release misfolded proteins from aggregates and direct them to the proteasome for degradation (19).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 47,
      "target": 92,
      "key": "4e29068d84442395f4c1a5ab7e4497e3e1224aa42796415e290ff3a06418d7e4c6a368d450b68dd562c4aa3cae6316f0e10c550962811302a89194a7d3e37c52"
    },
    {
      "line": 254,
      "relation": "negativeCorrelation",
      "evidence": "Experiments examining the effects of Aβ on proteasomal activity in vitro revealed an inhibitory effect on the chymotrypsin-like properties of the 20S core (73), consistent with observations of impaired proteasome function in AD patient brains (74). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 47,
      "target": 86,
      "key": "b013d2fcf16091f38c82f62e4e411d7ca645463d3169654c75d4c2e2ed8bf38e159851d29b3c3c916a0c7859f337a1e21b808f258759fe22b53e14f7f7c61586"
    },
    {
      "line": 141,
      "relation": "increases",
      "evidence": ". Proteins can be degraded either individually or en masse by proteasomes (20) or lysosomes (21), respectively. ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 12,
      "target": 36,
      "key": "aca20b8f7097b061d4f0b781bc55475500b2c14f870e11cccb34f50d8fa2f9e8469ce5cec865a99c722d13daffdec5ef399fae15caf8a603e9065260b50421dd"
    },
    {
      "line": 152,
      "relation": "decreases",
      "evidence": " Alternatively, bulkier substrates, such as large inclusions, can be directed to the lysosome, a membrane-bound organelle containing a host of nonspecific proteases that can degrade a wide range of substrates (21). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 12,
      "target": 92,
      "key": "b2a7c74169a842a49ddf37d3413d982a09235fe63b3a376da5e7b55c072a80533b04d035e35009b2a9f8b12b914d95ec6509836de41c30fbd4995d0d1c579f70"
    },
    {
      "line": 157,
      "relation": "increases",
      "evidence": "Upon increased levels of nonnative proteins, HSF1 is released from its repressive complex, acquires DNA-binding activity through homotrimerization, and rapidly translocates to the nucleus to induce expression of genes encoding molecular chaperones (7, 35).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 25,
      "target": 62,
      "key": "a591607356485c43b9df92bf5e9f7d39fbf1112aec6d928a64f60f3aa4db92c313bb12394796a83021ebc74594033c87e800b7e7143d2f3c3014dac1599df6cb"
    },
    {
      "line": 171,
      "relation": "increases",
      "evidence": " IRE1 is a transmembrane protein with kinase and endoribonuclease (RNase) activity that senses misfolding in the ER directly, leading to autophosphorylation, oligomerization, and acquisition of RNase activity (8).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "name": "kin",
          "namespace": "bel"
        }
      },
      "source": 25,
      "target": 60,
      "key": "e03a30d7e31cd2330645534c0ffc6cedd1e97a9caf6a070b28581ebc1178a3791f8d68734eb4699feace0023682f4bf55e2dacbd0ee4955b706e62435ceec3a1"
    },
    {
      "line": 158,
      "relation": "increases",
      "evidence": "Upon increased levels of nonnative proteins, HSF1 is released from its repressive complex, acquires DNA-binding activity through homotrimerization, and rapidly translocates to the nucleus to induce expression of genes encoding molecular chaperones (7, 35).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "MESH",
            "name": "Cytosol"
          },
          "toLoc": {
            "namespace": "MESH",
            "name": "Cell Nucleus"
          }
        }
      },
      "source": 62,
      "target": 62,
      "key": "b9cbb6e016275ccfd74e6eb7b0513702137bc10a70a3c98cd52f2d45b546c541b33e98377fe893e339093d1dabfa635108fb67d2f64cbb4ae065a62ea89e5702"
    },
    {
      "line": 159,
      "relation": "increases",
      "evidence": "Upon increased levels of nonnative proteins, HSF1 is released from its repressive complex, acquires DNA-binding activity through homotrimerization, and rapidly translocates to the nucleus to induce expression of genes encoding molecular chaperones (7, 35).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        }
      },
      "source": 62,
      "target": 11,
      "key": "82c430acf5312e41d42db930022d573b25d772d69921f624c033d30669d39817b7b852af553ceff1f7fabaefbcfa098708840ddac0ccb3fdf61baa5c6429520b"
    },
    {
      "relation": "hasVariant",
      "source": 62,
      "target": 63,
      "key": "a9b04ed68ca42e4f99853ccee33cfad36d05949ebae1a4901b4b8d408ddb6a9e86bc18de7db951d234ce6714b4c2c4f80fda843ac9003cf9c905c631c1193a8f"
    },
    {
      "line": 324,
      "relation": "association",
      "evidence": "Constitutive activation of HSF1 is detrimental to cells and increased expression, and activity of HSF1 has been linked to multiple forms of cancer, highlighting the need for appropriate and balanced activation of stress response pathways as and when required throughout life (122).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 62,
      "target": 93,
      "key": "eb78f3be292be0a9d057832822fc3d9278ad94e9b3682f9753ab7f2aa27f56e6252df2fc82ac2fcb77e405388028d8968328ca3fc963d6d579a58017f36e8201"
    },
    {
      "line": 164,
      "relation": "decreases",
      "evidence": "Once stress has been relieved, HSF1 activity is repressed through acetylation and binding to molecular chaperones (34, 36, 37).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 63,
      "target": 62,
      "key": "a2b4d2fe65b709a29da88ee64e78fd13954a7290a15039a07f8f9b2e5a3d81dab01a37c93f633666d17821a3c835c2f1056a7874ae01e8911817194225b489cd"
    },
    {
      "relation": "hasComponent",
      "source": 37,
      "target": 11,
      "key": "b131113064d83d595658389361a96657347bc2461e8a55718d6bce679638335506ffbb2023d25ec4bbf2ccdec9fb1a26e6c311c0e755f230c7c7fbb069dba589"
    },
    {
      "relation": "hasComponent",
      "source": 37,
      "target": 62,
      "key": "625f6daa78599f89cf28e1874c2b819709bee5bd07810014adbdb3974263a3d39956a5c38ad1b731e296d02773a7538f2681aa64859779727ff326f537345c7f"
    },
    {
      "line": 165,
      "relation": "decreases",
      "evidence": "Once stress has been relieved, HSF1 activity is repressed through acetylation and binding to molecular chaperones (34, 36, 37).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 37,
      "target": 62,
      "key": "db031c7a04019b6176309c6c00a29b71c51ad728e04c3e31e60eb6064f582b9da5ecac2ccbb6dbf90627e50a21799944fbfc232311d8ba6acdd52bac2dd188d2"
    },
    {
      "relation": "hasVariant",
      "source": 60,
      "target": 61,
      "key": "1ece4ee92251290a51d0749b5d678b72035e53809fc9348e5947547a0cb97a742342aa62f0d56c2222c3d0508b6a438b394d7effb7b181205e473592a54abc84"
    },
    {
      "line": 172,
      "relation": "increases",
      "evidence": " IRE1 is a transmembrane protein with kinase and endoribonuclease (RNase) activity that senses misfolding in the ER directly, leading to autophosphorylation, oligomerization, and acquisition of RNase activity (8).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "kin",
          "namespace": "bel"
        }
      },
      "source": 60,
      "target": 61,
      "key": "6212ccbd7fb4bb91cfa9eb38f239670442191f601fecbbb5830f6e5b0c21d544159fbae67fc8bf9fdda6fb9681a8bf8a83e262dd93b093d02e9fc606ca7baebe"
    },
    {
      "line": 180,
      "relation": "increases",
      "evidence": "This process allows active IRE1 to cleave XBP1 messenger RNA (mRNA), thereby generating a spliced transcript (XBP1s) that encodes a stable form of XBP1 that binds DNA and induces transcription of UPR target genes (8).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "GO",
          "name": "ribonuclease activity"
        }
      },
      "source": 60,
      "target": 82,
      "key": "fc89cc3a842c322401261ee1eda811bc75fbb352ff7bb0448bf68579a77cba122937768035ee04d594b631154d8b2be26ae020664eda6ee6a66d5100a65f4220"
    },
    {
      "line": 173,
      "relation": "increases",
      "evidence": " IRE1 is a transmembrane protein with kinase and endoribonuclease (RNase) activity that senses misfolding in the ER directly, leading to autophosphorylation, oligomerization, and acquisition of RNase activity (8).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "GO",
          "name": "ribonuclease activity"
        }
      },
      "source": 61,
      "target": 60,
      "key": "d6bdeb971f53f473fb6d3dabad2036c414bb8bc99c1a25bf02e1f2e75063ebf31587350560417815ca72fb1816a3221b10c8a4563ec4e52ccfd2e1b3183c542a"
    },
    {
      "line": 181,
      "relation": "increases",
      "evidence": "This process allows active IRE1 to cleave XBP1 messenger RNA (mRNA), thereby generating a spliced transcript (XBP1s) that encodes a stable form of XBP1 that binds DNA and induces transcription of UPR target genes (8).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        }
      },
      "source": 82,
      "target": 25,
      "key": "a1ead0c9149de76af67b0683d6e5033ea9a4b0fd2f73ad09f1c5610d1d60a9fade6cb37a3969aff062abb44f823d9cb5f8a691bf24cdf4fb538f42b1778a1a0f"
    },
    {
      "line": 186,
      "relation": "increases",
      "evidence": " In parallel, ER stress promotes the relocation of ATF6 from the ER membrane to the Golgi apparatus, where it is cleaved by SP1 and SP2 proteases.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "MESH",
            "name": "Endoplasmic Reticulum"
          },
          "toLoc": {
            "namespace": "MESH",
            "name": "Golgi Apparatus"
          }
        }
      },
      "source": 30,
      "target": 51,
      "key": "c230e06e6d025b114fd85b0d3fefaa2d7ffda44c502a122e890b823119047b6794f458d532cf0ab723bf3a6fd10770b24bf5f912fc4026b903b350e2a6c01405"
    },
    {
      "line": 205,
      "relation": "increases",
      "evidence": " Finally, a third ER transmembrane protein, PERK, promotes translation of the TF ATF4 by phosphorylating the translation initiation factor eIF2α in response to ER stress.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "name": "kin",
          "namespace": "bel"
        }
      },
      "source": 30,
      "target": 57,
      "key": "a60bba917b200f81e52bce5553252a382f3362e30b9159001cedc6860528a362eb0d92e3a97e3d4a4652c86ce2778309a1f8aa1275015fc586affe164fa07fa9"
    },
    {
      "line": 305,
      "relation": "negativeCorrelation",
      "evidence": " Disruption of the ATF6 arm of the UPR(ER) is reported to occur in mouse models of HD and a VAPB cell model of ALS, suggesting that differential changes in UPR arms may be a feature of disease progression (102, 103). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "Species": {
          "10090": true
        }
      },
      "source": 51,
      "target": 87,
      "key": "b9992d5a44deb0192030537be64204dedf26c2deb1b1c4ec957e8713ca2a2fb2c8988f2900c93a2c84068cb0bffeee64adae500fd207b1a617a52e5af2f7425a"
    },
    {
      "line": 306,
      "relation": "negativeCorrelation",
      "evidence": " Disruption of the ATF6 arm of the UPR(ER) is reported to occur in mouse models of HD and a VAPB cell model of ALS, suggesting that differential changes in UPR arms may be a feature of disease progression (102, 103). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "Species": {
          "10090": true
        }
      },
      "source": 51,
      "target": 88,
      "key": "dbdf9aa35f8d7a74e6b5a5890f936b83088348ab74bb33812a558e6757db359fbda6cc73759a78264d48bb2c129df35383c7deb181be717fb2fd54b52c6fac8e"
    },
    {
      "line": 188,
      "relation": "decreases",
      "evidence": " In parallel, ER stress promotes the relocation of ATF6 from the ER membrane to the Golgi apparatus, where it is cleaved by SP1 and SP2 proteases.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Golgi Apparatus": true
        }
      },
      "source": 72,
      "target": 51,
      "key": "7473f76be56222126f24d695c007e9e836b7c1b96969ccfe467132a66afe067596f97c2ce5f77ab2eb327f9bbb472e644d8e8f76956f5781e8756c4b3da1708c"
    },
    {
      "line": 190,
      "relation": "increases",
      "evidence": " In parallel, ER stress promotes the relocation of ATF6 from the ER membrane to the Golgi apparatus, where it is cleaved by SP1 and SP2 proteases.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Golgi Apparatus": true
        }
      },
      "source": 72,
      "target": 49,
      "key": "738b30c5de2e787bf46701e72c1786a6a52bae810520a4894e4fbfdcfac47d749cd0d6c48f4ac30440fbb7a45076a60addb3cb84ecf5a1182af125360713754c"
    },
    {
      "line": 189,
      "relation": "decreases",
      "evidence": " In parallel, ER stress promotes the relocation of ATF6 from the ER membrane to the Golgi apparatus, where it is cleaved by SP1 and SP2 proteases.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Golgi Apparatus": true
        }
      },
      "source": 73,
      "target": 51,
      "key": "803d7c4f53727dad19da083a8c4046413156d7ea5866c1aae3056d941d9d9639bbbb97e6fa603b3fb5d0a3159fb701095c327271a42220e257e2aeb37220a7f2"
    },
    {
      "line": 191,
      "relation": "increases",
      "evidence": " In parallel, ER stress promotes the relocation of ATF6 from the ER membrane to the Golgi apparatus, where it is cleaved by SP1 and SP2 proteases.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Golgi Apparatus": true
        }
      },
      "source": 73,
      "target": 49,
      "key": "37752ef173d426da48d03329fab3662941cec3adbec4bbd644735320d9e1b3662f75876f5ef36b5622fa8ef819c09cd609d711c8bf698a5fda399d0d686f6898"
    },
    {
      "line": 197,
      "relation": "increases",
      "evidence": "The cytosolic N-terminal fragment of ATF6 that is generated translocates to the nucleus, binds DNA, and drives expression of a complementary set of UPR genes (8).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "subject": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "MESH",
            "name": "Cytosol"
          },
          "toLoc": {
            "namespace": "MESH",
            "name": "Cell Nucleus"
          }
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        }
      },
      "source": 49,
      "target": 49,
      "key": "26412a48f50a4cb57863bcc25fa13d20e5db687beaf943e01758877dbd5f9e52c6d6864a4094078eac2ccbcb51f5e31be83c226f9c01f78f5351a77fb99faed8"
    },
    {
      "line": 198,
      "relation": "increases",
      "evidence": "The cytosolic N-terminal fragment of ATF6 that is generated translocates to the nucleus, binds DNA, and drives expression of a complementary set of UPR genes (8).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        }
      },
      "source": 49,
      "target": 25,
      "key": "bb550cb7daceb77fac6611aa7e85613ca55e0a22ceac4fddbec971dd4bd105d5814ec01ae5fb7de6bbfa35f0209cf2f199999dd8372f9e525b4a5631571aec88"
    },
    {
      "line": 206,
      "relation": "increases",
      "evidence": " Finally, a third ER transmembrane protein, PERK, promotes translation of the TF ATF4 by phosphorylating the translation initiation factor eIF2α in response to ER stress.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "kin",
          "namespace": "bel"
        }
      },
      "source": 57,
      "target": 59,
      "key": "968284b2db4c679c9ed45cdc9bbb0da814eb2e14c5c830f15d54d2c82c235ec80b047553a7c1e7e01a2eed777adf89082901daf8bdc5bb1d308300a0cf276513"
    },
    {
      "line": 207,
      "relation": "increases",
      "evidence": " Finally, a third ER transmembrane protein, PERK, promotes translation of the TF ATF4 by phosphorylating the translation initiation factor eIF2α in response to ER stress.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        }
      },
      "source": 59,
      "target": 58,
      "key": "bc70ec14e97268b86b94937c63e5c0505eae64fe65e8d5ac2aca0f1dc55462bc4edb48b58712ac33a2fcdadffdedd65df6bdaa80de60b2e5f34e4e361fd82c13"
    },
    {
      "relation": "hasVariant",
      "source": 58,
      "target": 59,
      "key": "e16ce97626ff0848c0e3a6a250b01d22525b3eb8963e68259e8930ae75d8bfbbc3de54568705254d0b61a215a6932ec17ada476ca7355f25b10639066d7c9cb0"
    },
    {
      "line": 208,
      "relation": "increases",
      "evidence": " Finally, a third ER transmembrane protein, PERK, promotes translation of the TF ATF4 by phosphorylating the translation initiation factor eIF2α in response to ER stress.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        }
      },
      "source": 58,
      "target": 50,
      "key": "78737903c8eba44b58fe2a67e9362e0eae9769cc24866ae8d4c83b5eae5b4dca552e5838fc1f70ac2f0f7d97cf7752f29dd53e8e75c71a627b60e20b48f4e1f8"
    },
    {
      "line": 215,
      "relation": "increases",
      "evidence": " Under these conditions, ATF4 mRNA is preferentially translated, leading to selective expression of the proapoptotic TF CHOP, which elicits apoptosis if ER stress is not resolved, presumably to ensure that irreversibly damaged cells are removed from the population.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 50,
      "target": 55,
      "key": "0bec13103d1b6726a5491b6ad0dae0c64d9b5370c21fd9ab417c42eeea821326711ddc8af440684b4a29a7563fa9036a285badf48609e65f5089796fc39d5b66"
    },
    {
      "line": 216,
      "relation": "increases",
      "evidence": " Under these conditions, ATF4 mRNA is preferentially translated, leading to selective expression of the proapoptotic TF CHOP, which elicits apoptosis if ER stress is not resolved, presumably to ensure that irreversibly damaged cells are removed from the population.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 55,
      "target": 20,
      "key": "9b22195696808b548852b9ca0d03b07137265097282859a9311a2edfc40d4ed8ccc45598327e3993e6b073f6600c486de93735b9a6ffa4407ab2bcdb6c913bf2"
    },
    {
      "line": 221,
      "relation": "increases",
      "evidence": "Cerebellar granular neurons were found to express high levels of HSP70 in response to mHTT expression but not mAtaxin-1.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "cerebellar granule cell": true
        }
      },
      "source": 69,
      "target": 45,
      "key": "f9390f636ddf8e74c606c458771ac2e309edecd9710c102bdf60bea499dd3881d43f97373e15fc710da192682dc3e0b51dbadab72678220b7ce5157281aacc4d"
    },
    {
      "relation": "hasVariant",
      "source": 68,
      "target": 69,
      "key": "a3ac61ee6ec4e9b3af47845dbe04b3de658393e1d87be866f3fc491ce0722391f8d21e748e8816d98859b534dff8a41ea1d7df7603199741e1d45d50c1675f96"
    },
    {
      "line": 222,
      "relation": "causesNoChange",
      "evidence": "Cerebellar granular neurons were found to express high levels of HSP70 in response to mHTT expression but not mAtaxin-1.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "cerebellar granule cell": true
        }
      },
      "source": 53,
      "target": 45,
      "key": "ff0d7fcc54c6dc1a0be19baafb7f297bf8ac3af456f11f1f3163ddcd31358911c564ed16bf42369eb15936526a27b4d78e4e2e3b87661a013bcaf5e3aac80478"
    },
    {
      "relation": "hasVariant",
      "source": 52,
      "target": 53,
      "key": "3205016a15d660315762ef963f74ff78524eaacf1cab8e6a48cd3bbdbda859a98498f5b4897ef4f80411cd4cb59e1a21a958a1a933aab466d8468d0fb558c363"
    },
    {
      "line": 229,
      "relation": "positiveCorrelation",
      "evidence": "Furthermore, increased levels of HSP70 were found in the cerebellar cortex of human HD brain samples but not in tissue from unaffected individuals or from brains of PD patients (57).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "source": 88,
      "target": 45,
      "key": "84cc76b72fe4aed0ba44f305a0d90695b3b371042cada27094301b606ad1322a8d77c466ec8e2d6ad868f5302f31a00cf3c57784b15d4a9433eab1e573f0bc17"
    },
    {
      "line": 306,
      "relation": "negativeCorrelation",
      "evidence": " Disruption of the ATF6 arm of the UPR(ER) is reported to occur in mouse models of HD and a VAPB cell model of ALS, suggesting that differential changes in UPR arms may be a feature of disease progression (102, 103). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "Species": {
          "10090": true
        }
      },
      "source": 88,
      "target": 51,
      "key": "2f770274708d0643fa80b9b8e7a473ec1a46ed8d3b461e684d99990e32deb269815066cc5a30850903bc4dc41328f020ac80a753e0da270f453ca31d2c3e37a4"
    },
    {
      "line": 237,
      "relation": "association",
      "evidence": "Protein aggregation is recognized as a hallmark of neurodegenerative disease by the consistent appearance of detergent-insoluble inclusions and aggregates in the nucleus and cytoplasm of neurons.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        },
        "CellStructure": {
          "Cytoplasm": true,
          "Cell Nucleus": true
        }
      },
      "source": 90,
      "target": 92,
      "key": "550ed982fe6be9ff8db292e0e44f45b7937a4f4bb88b27ee1c5c0d3464a2703ed2bb023c9ab2dcb06f33b7e28713312f61e1cef7f365b30eb9a3d1243a7b68dd"
    },
    {
      "line": 244,
      "relation": "negativeCorrelation",
      "evidence": "Studies of chaperone levels in tissue culture and mouse models of polyQ disease showed that the levels of HSP70 (HSPA1A/B) and DNAJ/HSP40 (DNAJB1), as well as some cochaperones, decline with protein aggregation (64, 65).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 64,
      "target": 92,
      "key": "03ef5f690d27c381281cd68eedacaad0d9a1aae0dc1129e46df383816aa08fecbad037a8a6d95fcd7a325f3313559c65b390d62ba6c503e02889ba4b8fb09d95"
    },
    {
      "line": 245,
      "relation": "negativeCorrelation",
      "evidence": "Studies of chaperone levels in tissue culture and mouse models of polyQ disease showed that the levels of HSP70 (HSPA1A/B) and DNAJ/HSP40 (DNAJB1), as well as some cochaperones, decline with protein aggregation (64, 65).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 65,
      "target": 92,
      "key": "e8dc5476159dcccc11769f484de6427159a19857afd0601d6ea02bb52f6d862bd39630877da8aa6c0e21dd462bfd4642923ac0f9bb6ca16ff94d02e2313dae1b"
    },
    {
      "line": 252,
      "relation": "decreases",
      "evidence": "Experiments examining the effects of Aβ on proteasomal activity in vitro revealed an inhibitory effect on the chymotrypsin-like properties of the 20S core (73), consistent with observations of impaired proteasome function in AD patient brains (74). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 1,
      "target": 47,
      "key": "d34b0ac8e667876b55a4f33f61236d9f7239d336ed1bc2cd85b5eaa789d5278be638e403d4d4068bdc604d818e7cee62d12bb1a96be8ccc4681fca6db6f64874"
    },
    {
      "line": 254,
      "relation": "negativeCorrelation",
      "evidence": "Experiments examining the effects of Aβ on proteasomal activity in vitro revealed an inhibitory effect on the chymotrypsin-like properties of the 20S core (73), consistent with observations of impaired proteasome function in AD patient brains (74). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 86,
      "target": 47,
      "key": "9419a136b59a564dea0a7a87bd10044056196f01d062a45367bc3d600dfc2be21b8bcf6777916beb5a76765466039aca5501e85f0b5e910c750c8b1c1cbd2247"
    },
    {
      "line": 269,
      "relation": "negativeCorrelation",
      "evidence": " Consistent with a role of autophagy in disease, AD patient tissues exhibit impaired initiation of macroautophagy and an excess of autophagic vacuoles in dystrophic neurites, possibly due to impaired targeting of the vacuolar ATPase to the lysosome (86, 87).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 86,
      "target": 27,
      "key": "c35f4ef3db12b972144764756152d003a64ea8b88b00a1cc0e31da17e31aa0db0dd9cfc6108bf90073adc4232b20420eddfd6fe7615d06ba2a5c7c7b57f20bb3"
    },
    {
      "line": 262,
      "relation": "decreases",
      "evidence": " Mice deficient for the autophagy-related genes Atg5 and Atg7 exhibit severe neurodegeneration (84, 85), and the expression of disease- associated proteins is reported to exert differential inhibitory effects on autophagic pathways.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "source": 84,
      "target": 29,
      "key": "4bbf3bc98caa82e9e8e26abcab32f3462f1af5aaf89288f3daded943d22be836349e91d681b81ae272bc9b233e4d4283015aaab41e076c5f2f558ae33c161769"
    },
    {
      "line": 263,
      "relation": "decreases",
      "evidence": " Mice deficient for the autophagy-related genes Atg5 and Atg7 exhibit severe neurodegeneration (84, 85), and the expression of disease- associated proteins is reported to exert differential inhibitory effects on autophagic pathways.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "source": 85,
      "target": 29,
      "key": "9b98d4041d99d08d8111abb6bab2da8cd332f0de883ffd6a7ddcec6606a72cde79cd8acee8eef4e2ce7c3ac2f49b1474046d84023806cc241156f6f1845ccac0"
    },
    {
      "line": 269,
      "relation": "negativeCorrelation",
      "evidence": " Consistent with a role of autophagy in disease, AD patient tissues exhibit impaired initiation of macroautophagy and an excess of autophagic vacuoles in dystrophic neurites, possibly due to impaired targeting of the vacuolar ATPase to the lysosome (86, 87).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 27,
      "target": 86,
      "key": "e1da7fb94442a8fa6f243f533e7510c6a0a24c79069574559979fcf124d6ef08476a981221a53a4dd82480ba6766f79378e8558c2854039541dd730635d72e55"
    },
    {
      "line": 273,
      "relation": "decreases",
      "evidence": "In contrast, α-synuclein overexpression impairs autophagy in mammalian cells and mice through reduced expression of RAB1A, thereby inhibiting autophagosome formation (88). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 75,
      "target": 26,
      "key": "f73a89bf3e316d6e89d12b3cff016b4a74f8e0cf7119e7ed5062c39fe843a8420dfbc06b5062bf2781e41e621d0a14eb7952c9aa8869c481df5f32843c3200e4"
    },
    {
      "line": 274,
      "relation": "decreases",
      "evidence": "In contrast, α-synuclein overexpression impairs autophagy in mammalian cells and mice through reduced expression of RAB1A, thereby inhibiting autophagosome formation (88). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 75,
      "target": 74,
      "key": "2a891c06ddea91312c3c5056360015c4363906b010c42f02030611ef2e96d436be8efde689c6f0e2eab6a24d5a33e01694ca2967cc61c775b6615dbbfbf3582f"
    },
    {
      "relation": "hasVariant",
      "source": 75,
      "target": 76,
      "key": "be326115b03b23c8f9535c21a847d21c9d71e9ca0a6e59ec5908fdafce0eaeeec33010beead981cf64164710a885bfd84590f8605663c0c087fcfebbf7ab6580"
    },
    {
      "line": 275,
      "relation": "increases",
      "evidence": "In contrast, α-synuclein overexpression impairs autophagy in mammalian cells and mice through reduced expression of RAB1A, thereby inhibiting autophagosome formation (88). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "source": 74,
      "target": 21,
      "key": "fc9cf650b90419a9a86546a3879f4fe52142db3435cf427fff6788a3ed09c66b9c728b993faf394efa85ba02f241f021471c1f41a9615ea4ee8e8862adbaa199"
    },
    {
      "line": 280,
      "relation": "increases",
      "evidence": "In contrast to findings in HD, AD, and PD, a recent study has suggested that autophagy is enhanced in ALS mice.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "source": 87,
      "target": 26,
      "key": "56f9a853d98bf1c268f00252322c0b11adc8551df7c0fcdca5a2ede83f9325d68a2f64926881d7bc884bad343f09fcde6b677b7020e9cd03baaba501b2dd11cb"
    },
    {
      "line": 305,
      "relation": "negativeCorrelation",
      "evidence": " Disruption of the ATF6 arm of the UPR(ER) is reported to occur in mouse models of HD and a VAPB cell model of ALS, suggesting that differential changes in UPR arms may be a feature of disease progression (102, 103). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "Species": {
          "10090": true
        }
      },
      "source": 87,
      "target": 51,
      "key": "8bc889b52ca730374a436df13dd6575c6fea8b74b8bbe0140f50c643fb7486c7a02d7e3d263abcbf93665c7d5af85e2db6722d2a36dfa4fbb0fe2732fb9a4db9"
    },
    {
      "line": 290,
      "relation": "decreases",
      "evidence": " Reduced levels of lipofuscin, LC3, and p62 have been observed in motor neurons of SOD1(G85R) mice (92). Treatment with the autophagy inhibitor chloroquine restored lipofuscin, LC3, and p62 levels in motor neurons, suggesting that mutant SOD1 causes hyperactive autophagy in mice (92). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 78,
      "target": 0,
      "key": "5d5af5a17ae195d3064d39bef88f80d877074ce7437f3190ed12b56bfe35ef4e01a5bb46ec09dcbcba198184eb1cc442e21cc96b0156bd5d4de35df1128a4be8"
    },
    {
      "line": 291,
      "relation": "decreases",
      "evidence": " Reduced levels of lipofuscin, LC3, and p62 have been observed in motor neurons of SOD1(G85R) mice (92). Treatment with the autophagy inhibitor chloroquine restored lipofuscin, LC3, and p62 levels in motor neurons, suggesting that mutant SOD1 causes hyperactive autophagy in mice (92). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 78,
      "target": 70,
      "key": "149772b460239bca0e6d6b80ac1e4d4304a7b85910e304f0a967d59941fc090ca460e41673bae7e78c2f3e051d5044661aaa863af9766c17ec03411f03e4b5eb"
    },
    {
      "line": 292,
      "relation": "decreases",
      "evidence": " Reduced levels of lipofuscin, LC3, and p62 have been observed in motor neurons of SOD1(G85R) mice (92). Treatment with the autophagy inhibitor chloroquine restored lipofuscin, LC3, and p62 levels in motor neurons, suggesting that mutant SOD1 causes hyperactive autophagy in mice (92). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 78,
      "target": 79,
      "key": "03379113bcc6a4aed345d8b912374bd1085f6c1cee232f791e1819bee40f37df78b1e44cc52e65a0c64e65aaffee86540f11e1950d6f08cb886e600424627ac3"
    },
    {
      "line": 297,
      "relation": "increases",
      "evidence": " Reduced levels of lipofuscin, LC3, and p62 have been observed in motor neurons of SOD1(G85R) mice (92). Treatment with the autophagy inhibitor chloroquine restored lipofuscin, LC3, and p62 levels in motor neurons, suggesting that mutant SOD1 causes hyperactive autophagy in mice (92). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 78,
      "target": 26,
      "key": "a0a4f7b45b2d99e4ff0c378bbfc04141ccf719fae3824f6b12663d74aaff7abf433c008f2327df2394f02da11b873ad40c4945cb79ca2fe710a68ee514af3919"
    },
    {
      "relation": "hasVariant",
      "source": 77,
      "target": 78,
      "key": "b00f0606576dca101e29f64a13c9d1aafbdee7e3c60d2001b9cd98f812f41c835645035c529358a57ffd023df5eac8b125f8d0e7c4e53383df1c9caa1cf977ec"
    },
    {
      "line": 293,
      "relation": "decreases",
      "evidence": " Reduced levels of lipofuscin, LC3, and p62 have been observed in motor neurons of SOD1(G85R) mice (92). Treatment with the autophagy inhibitor chloroquine restored lipofuscin, LC3, and p62 levels in motor neurons, suggesting that mutant SOD1 causes hyperactive autophagy in mice (92). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 2,
      "target": 26,
      "key": "1fde55b04c9c1adf5bb0ef1eeb8901ec80cff307f69d973930558b212a138e47320967357ac64573d9194fffbddeff1ec8218e63d6504291d10939da35fa358b"
    },
    {
      "line": 294,
      "relation": "increases",
      "evidence": " Reduced levels of lipofuscin, LC3, and p62 have been observed in motor neurons of SOD1(G85R) mice (92). Treatment with the autophagy inhibitor chloroquine restored lipofuscin, LC3, and p62 levels in motor neurons, suggesting that mutant SOD1 causes hyperactive autophagy in mice (92). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 2,
      "target": 0,
      "key": "07bb21d7561ab5f70ad77b573afbd594f7438ef2bfd17abeb580872eb2163ac93ebfa3ba53c11e5169c3533baf9bc662847bdee575c9b34f915a142cfa15491b"
    },
    {
      "line": 295,
      "relation": "increases",
      "evidence": " Reduced levels of lipofuscin, LC3, and p62 have been observed in motor neurons of SOD1(G85R) mice (92). Treatment with the autophagy inhibitor chloroquine restored lipofuscin, LC3, and p62 levels in motor neurons, suggesting that mutant SOD1 causes hyperactive autophagy in mice (92). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 2,
      "target": 70,
      "key": "268b7b35b5eee32f34d85ffacc6fac0f139c93ead23a8276ecb34425820c705666e3a4f019dae622d48961d4de03178f1512b27dcd7c5f04c1a1b14b8abaa3cf"
    },
    {
      "line": 296,
      "relation": "increases",
      "evidence": " Reduced levels of lipofuscin, LC3, and p62 have been observed in motor neurons of SOD1(G85R) mice (92). Treatment with the autophagy inhibitor chloroquine restored lipofuscin, LC3, and p62 levels in motor neurons, suggesting that mutant SOD1 causes hyperactive autophagy in mice (92). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Species": {
          "10090": true
        },
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 2,
      "target": 79,
      "key": "0d04f5e4ae17de542d0043efbd72e0ceb4e09eb4738a4c5df4cfae4b1b2a4b28f236f4c10cdf8e9643ae8eb837cc31f45e5574a93c696540e20f8780b68bf496"
    },
    {
      "line": 324,
      "relation": "association",
      "evidence": "Constitutive activation of HSF1 is detrimental to cells and increased expression, and activity of HSF1 has been linked to multiple forms of cancer, highlighting the need for appropriate and balanced activation of stress response pathways as and when required throughout life (122).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 93,
      "target": 62,
      "key": "b9f7e4410baa37023ba10e0994773ad0e0b89f4c1656a701b2efa43dc9428dc9fb9381301dac91bb2c6fcafcb16dd8d06832f40da76eaa110bbea7eb092b73f8"
    },
    {
      "line": 337,
      "relation": "decreases",
      "evidence": "One strategy is to directly activate HSF1, thereby increasing the expression of multiple molecular chaperones simultaneously. This approach has been traditionally achieved by inhibition of HSP90 with compounds that bind the N-terminal ATP-binding pocket, such as radicicol, geldanamycin, or 17-AAG (64, 132–134). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 6,
      "target": 44,
      "key": "4eaf7dea93cb9f538b3f343d164f7f845f67b31b8c22c978f52584619945977831e7e7550d78005a2bb2039a7cd17816574fa6e6ed6289fd1e68bf2497f5b709"
    },
    {
      "line": 338,
      "relation": "decreases",
      "evidence": "One strategy is to directly activate HSF1, thereby increasing the expression of multiple molecular chaperones simultaneously. This approach has been traditionally achieved by inhibition of HSP90 with compounds that bind the N-terminal ATP-binding pocket, such as radicicol, geldanamycin, or 17-AAG (64, 132–134). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 4,
      "target": 44,
      "key": "68954281ceb0c191e55202c1279f6f574e20ca6f053aa2d7d5bb0b6e23def4819ece0c71453a68087462090d70d1d0da12f43c417e9af5b6c68ee32aaa5f9438"
    },
    {
      "line": 339,
      "relation": "decreases",
      "evidence": "One strategy is to directly activate HSF1, thereby increasing the expression of multiple molecular chaperones simultaneously. This approach has been traditionally achieved by inhibition of HSP90 with compounds that bind the N-terminal ATP-binding pocket, such as radicicol, geldanamycin, or 17-AAG (64, 132–134). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 8,
      "target": 44,
      "key": "cc5d4bde30b43ab7743d72c914689f70bd6e5718bb59ebb62e7ab50b43a0fc9ea09aff763186b76b1aec67396f59aa91757aed183f4ba408c32c7fa48c97a9e7"
    },
    {
      "line": 344,
      "relation": "increases",
      "evidence": "High-throughput screens in yeast and HeLa cells identified HSF1A and F1, respectively, as two small molecules that activate HSF1 independently of HSP90 inhibition (136, 137). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 15,
      "target": 62,
      "key": "0dc5770c31d4d021305a520616c8efe1978be217400957cbfa81c8851f5854bf999ed27fe5938cf0b900299f27e051cf537628b22fdfb9f89537ecbfb358051e"
    },
    {
      "line": 349,
      "relation": "decreases",
      "evidence": "HSF1A suppresses toxicity in cell and tissue culture models of HD and SCA-3/MJD and appears to activate HSF1 by impairing the activity of TRiC, a recently discovered negative regulator of HSF1.",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 15,
      "target": 42,
      "key": "9d36374bc3cc7e5b4e471a3512bce5b505886baaeb362a9adefdfb225e9533cb7fea4a400d6ff2529410473e8a792c54e151bd548fc6203a8253f437c0eae7de"
    },
    {
      "line": 356,
      "relation": "decreases",
      "evidence": "Treatment of cell, Drosophila, and mouse models of HD, SCA3/MJD, AD, PD, and ALS with the mTOR inhibitor rapamycin (or a derivative) reduces aggregation and suppresses disease (140– 143).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 48,
      "key": "b515bdacae597100ea3f24d68c7c3cd8948e82b42375c39826dbf332cc7304deda547c90e0172fc35e220fefbfb41bb6c451b8756670cde00fd176b20f0d3557"
    },
    {
      "line": 357,
      "relation": "decreases",
      "evidence": "Treatment of cell, Drosophila, and mouse models of HD, SCA3/MJD, AD, PD, and ALS with the mTOR inhibitor rapamycin (or a derivative) reduces aggregation and suppresses disease (140– 143).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 7,
      "target": 92,
      "key": "7464d8a0c0c20a2e5c1ff51f7ef5e0f55b3f9642241baa8d9ab061f96ea614863ca0c02ba291610c9a32002271b44adfaea38343f21145a5669b35b4a9a38ab4"
    },
    {
      "line": 358,
      "relation": "decreases",
      "evidence": "Treatment of cell, Drosophila, and mouse models of HD, SCA3/MJD, AD, PD, and ALS with the mTOR inhibitor rapamycin (or a derivative) reduces aggregation and suppresses disease (140– 143).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 7,
      "target": 88,
      "key": "06667920b40ad3e0c182cb5fee4838b435a980c10591041537f7cc6bd6770f2e369cd26ae8a6b6d7487abebcd73ac2aa0d987302edd6634b69f37423cbae3648"
    },
    {
      "line": 359,
      "relation": "decreases",
      "evidence": "Treatment of cell, Drosophila, and mouse models of HD, SCA3/MJD, AD, PD, and ALS with the mTOR inhibitor rapamycin (or a derivative) reduces aggregation and suppresses disease (140– 143).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 7,
      "target": 89,
      "key": "9c22f2ff0c1d6d6e1a96902fde1b85cb9c837e2299e7f717da1dac16f76d0cc43ddb92f31ce99b14b027e64b0571e5cd3c570cfe401e93e4cc16818702348f84"
    },
    {
      "line": 360,
      "relation": "decreases",
      "evidence": "Treatment of cell, Drosophila, and mouse models of HD, SCA3/MJD, AD, PD, and ALS with the mTOR inhibitor rapamycin (or a derivative) reduces aggregation and suppresses disease (140– 143).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 7,
      "target": 86,
      "key": "84bb95eed18d71974cbae9dbd4463bb2e63e9d4af83e2772b70d8394fb54343cf4711899b8e83fc0457af07dde458f86042404f478eb2d3fa6aa6d17db44cd67"
    },
    {
      "line": 361,
      "relation": "decreases",
      "evidence": "Treatment of cell, Drosophila, and mouse models of HD, SCA3/MJD, AD, PD, and ALS with the mTOR inhibitor rapamycin (or a derivative) reduces aggregation and suppresses disease (140– 143).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 7,
      "target": 91,
      "key": "b72861558df49b3754778276e70a2bdf5f0cc7e747d4b89eb817f4160f821e444720f27ca632248c6d5599111fdfcd7f8da3fc7b3777844fbbebc4a2457f1673"
    },
    {
      "line": 362,
      "relation": "decreases",
      "evidence": "Treatment of cell, Drosophila, and mouse models of HD, SCA3/MJD, AD, PD, and ALS with the mTOR inhibitor rapamycin (or a derivative) reduces aggregation and suppresses disease (140– 143).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 7,
      "target": 87,
      "key": "3dc6ed9ec0d482a61c0810815c6c91c63569b3ecd6d951222636a92697134307d9485e872a11d1bc23ab01908ee68820ed4a845d690c9ffae1f824046ed6ac70"
    },
    {
      "line": 367,
      "relation": "decreases",
      "evidence": "An in silico screen based on the structure of 10-NCP, an Akt inhibitor that potently induces autophagy (144), identified the molecules FPZ and MTM as potent activators of autophagic flux and clearance of TDP-43 in mammalian cells (145).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 13,
      "target": 43,
      "key": "e3b8df1a028e0632e9e5f339f2e650f9087f85928016b57deee4e28ad3bbe6d95772033c95a7af17299c9d8669900e239267f65d864d03c73c908989546579de"
    },
    {
      "line": 368,
      "relation": "increases",
      "evidence": "An in silico screen based on the structure of 10-NCP, an Akt inhibitor that potently induces autophagy (144), identified the molecules FPZ and MTM as potent activators of autophagic flux and clearance of TDP-43 in mammalian cells (145).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 13,
      "target": 26,
      "key": "90a6de17dc2ec2036a22858ee2daa3985127f9367a9f48d95f9606e93ddeaa51d5a2f88c29febec1437edb2c9bb00c7a7ba1cb56fbbc89fc281fa272b94b0049"
    },
    {
      "line": 369,
      "relation": "increases",
      "evidence": "An in silico screen based on the structure of 10-NCP, an Akt inhibitor that potently induces autophagy (144), identified the molecules FPZ and MTM as potent activators of autophagic flux and clearance of TDP-43 in mammalian cells (145).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 3,
      "target": 26,
      "key": "daab80b854a0a7dc2097d822a1275dc6b2ad1d53bb0e76c17b41396f9c4ae4f357f1e883bb6176548b0f1f8b00619cfa78245f1fc06dd85594e5020c5ff80528"
    },
    {
      "line": 372,
      "relation": "decreases",
      "evidence": "An in silico screen based on the structure of 10-NCP, an Akt inhibitor that potently induces autophagy (144), identified the molecules FPZ and MTM as potent activators of autophagic flux and clearance of TDP-43 in mammalian cells (145).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 3,
      "target": 80,
      "key": "ca299957233c9e5694bc3d448b30df061c7a50419e45be49fddf7ee1db4161440e46e667297332e9ce731a42f5db0198bace19309be4e9c331692392f17d5659"
    },
    {
      "line": 370,
      "relation": "increases",
      "evidence": "An in silico screen based on the structure of 10-NCP, an Akt inhibitor that potently induces autophagy (144), identified the molecules FPZ and MTM as potent activators of autophagic flux and clearance of TDP-43 in mammalian cells (145).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 5,
      "target": 26,
      "key": "077459ffe3254e6df75e84ad65e0ca56eef81b60df99452635f87f390ba44333bbd8d8be3740c4aee4e8583983ea13c3898b9e06330ee135b0fa59d58427cd5c"
    },
    {
      "line": 373,
      "relation": "decreases",
      "evidence": "An in silico screen based on the structure of 10-NCP, an Akt inhibitor that potently induces autophagy (144), identified the molecules FPZ and MTM as potent activators of autophagic flux and clearance of TDP-43 in mammalian cells (145).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 5,
      "target": 80,
      "key": "42127f86aacc556de3e4f828e735e8307005961d84b7b3b4dc9a082014e0725926fe47124f4ad2650a790f5907d1222a185bb0cde79d8d0b342122924b06b9af"
    },
    {
      "line": 377,
      "relation": "increases",
      "evidence": "A screen for autophagy inducers in yeast identified the molecules SMER-10, -18, and -28 as TOR-independent activators of autophagy (146). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 17,
      "target": 26,
      "key": "d02e4a2c616178550bfccb86348cc57dbe8f3c82a02f3fcbcc7384b0a2fa16bc97c9b054d7f098cc3514527cff4defabd1d11575bc0bbd44d2336e3b5d325a22"
    },
    {
      "line": 384,
      "relation": "decreases",
      "evidence": "Treatment of PC12 cells stably expressing mutant α-synuclein (A53T) with SMER-10, -18, or-28 significantly reduced levels of mutant α-synuclein, an effect that was enhanced by cotreatment with rapamycin (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 17,
      "target": 76,
      "key": "09f471e07a0cab41925ecdf144d295454189b06e7b378e00715e3229a758c6a1ea85cd1d0d6a6a74163c9e23f5b56d4e0eb715dbc5ab5bc5072511ae10a40265"
    },
    {
      "line": 393,
      "relation": "decreases",
      "evidence": "In addition, SMER-10, -18, and -28 were effective at suppressing mHTT aggregation and toxicity in COS-7 cells and flies (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 17,
      "target": 9,
      "key": "9e37029ffbff27d4337f5cfd0bc8679537e069ffe6170a1c30e2d15cb85a6b6be362047f21516c226b6b34d2332d5f2f0e72463861c90a5ecd5d01d748412b83"
    },
    {
      "line": 378,
      "relation": "increases",
      "evidence": "A screen for autophagy inducers in yeast identified the molecules SMER-10, -18, and -28 as TOR-independent activators of autophagy (146). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 18,
      "target": 26,
      "key": "456d9daaa095dad122ed1c7484b93716c64d59c79ee911f61cd2dc66b2fb2537c32db998be751f113935ff50e01f47a4f76124af93f7f287a1767698b309ba98"
    },
    {
      "line": 385,
      "relation": "decreases",
      "evidence": "Treatment of PC12 cells stably expressing mutant α-synuclein (A53T) with SMER-10, -18, or-28 significantly reduced levels of mutant α-synuclein, an effect that was enhanced by cotreatment with rapamycin (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 18,
      "target": 76,
      "key": "d2018e2579cef268e711e5c2a2ba0451bc2633f9db2afd67dd4ac683d0b3a6e5074056aee62a78744c373475f63a4f3027b67a1472b6ec1e97c239b547799fca"
    },
    {
      "line": 394,
      "relation": "decreases",
      "evidence": "In addition, SMER-10, -18, and -28 were effective at suppressing mHTT aggregation and toxicity in COS-7 cells and flies (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 18,
      "target": 9,
      "key": "64e5d2c8478f3c274d0c331bf35921cfec41716f814176146a6888ff64d3faeee3a8dc78d3dc9c5652f73f68fa2c4a4655c407febf403b0132f407d06974abdb"
    },
    {
      "line": 379,
      "relation": "increases",
      "evidence": "A screen for autophagy inducers in yeast identified the molecules SMER-10, -18, and -28 as TOR-independent activators of autophagy (146). ",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 14,
      "target": 26,
      "key": "ff03cd1588dace53e33c1891e96ea9e0b8e0456990a28f86e91844eb7b23f7850e9c7726b8d8a3bf4ea54c941b3a6e06d9dff7dbe892a4dc5a556f0cbc89b509"
    },
    {
      "line": 386,
      "relation": "decreases",
      "evidence": "Treatment of PC12 cells stably expressing mutant α-synuclein (A53T) with SMER-10, -18, or-28 significantly reduced levels of mutant α-synuclein, an effect that was enhanced by cotreatment with rapamycin (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 14,
      "target": 76,
      "key": "a7d2d36af4ab4cabed894d3c9a92fb7f7753ad996d0751607f065f8cccbf344d635eba0cee74567f79075b39047f05c90fe408624bb151a5c7ac7a344b3f7cf3"
    },
    {
      "line": 395,
      "relation": "decreases",
      "evidence": "In addition, SMER-10, -18, and -28 were effective at suppressing mHTT aggregation and toxicity in COS-7 cells and flies (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 14,
      "target": 9,
      "key": "89f8fb281f095f1314472b4f1329c91bb6364c2c860a23200d67c7219b3ca5ce7b19bed29671b163aeab4c300e3ca3840bc1d84025bc1e89606d4f7c155b6c23"
    },
    {
      "relation": "hasComponent",
      "source": 40,
      "target": 7,
      "key": "4e9f6a797a194a1dd3cea77744b6f233ecdc7d2b9a32a21b8755bdbaecc541f1681cbec0f9f519539b7f2e0ae079b8bdea0d624cd4fddea0c3055826498a00aa"
    },
    {
      "relation": "hasComponent",
      "source": 40,
      "target": 17,
      "key": "a8726f0d36e66b5ab4f55ae96bf8baf3ee62f4c56419371b1f22c18560ae9749bcdbe533c018f176ad20b49f4eb8fe319e56178f0269a273f6ca169a1990976c"
    },
    {
      "line": 387,
      "relation": "decreases",
      "evidence": "Treatment of PC12 cells stably expressing mutant α-synuclein (A53T) with SMER-10, -18, or-28 significantly reduced levels of mutant α-synuclein, an effect that was enhanced by cotreatment with rapamycin (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 40,
      "target": 76,
      "key": "4ac77235908e29aafdf35e166d79bd0b9617e77a791e43c4b7f790df5106fee497bb05feec60448be15c7085fae529d0fdf925d141ed6461715f0e6fb090ca43"
    },
    {
      "relation": "hasComponent",
      "source": 41,
      "target": 7,
      "key": "0b4ce24ab43b500276c78618bc2b446e291ad4a9078ff3bb4debbb9fb2dd6e9202b7a607f89f0b17b9cf84d8ce4847884dde20cebe3f6b1f4f7bf574086782bd"
    },
    {
      "relation": "hasComponent",
      "source": 41,
      "target": 18,
      "key": "242050e0e6ba69706d7459dd123d8f9b17f9bf4c42636588f918392671968063bef38686f6b52be3b2f806d0365d34d8381076abf5a1d8f858ea64f06db8972c"
    },
    {
      "line": 388,
      "relation": "decreases",
      "evidence": "Treatment of PC12 cells stably expressing mutant α-synuclein (A53T) with SMER-10, -18, or-28 significantly reduced levels of mutant α-synuclein, an effect that was enhanced by cotreatment with rapamycin (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 41,
      "target": 76,
      "key": "66527e1d8a00d4a088dda36d23de2836b781af74a7bfc4b3021da327e7e23eabef4bb60880017ded9ebdd679724907cac89ff63cb0100e2fdef413be5fb03b6e"
    },
    {
      "relation": "hasComponent",
      "source": 39,
      "target": 7,
      "key": "3260ed39ab71c9bb907b4c807b31bc9be047e746c1d055d74c7db856a3b9b9b3633c51b3819a0677587a493fe3a5a8235415c2ef6e4c5abb74dfbc25e95f53dd"
    },
    {
      "relation": "hasComponent",
      "source": 39,
      "target": 14,
      "key": "c7c4bae309b61fc400b67439beb3fdf65ee54906c4a5a6e6b40ce7efa51e4b92e22cab11057938d34adc6e2f0cae3c9b77089d8f59db3c32221e55ce706a2803"
    },
    {
      "line": 389,
      "relation": "decreases",
      "evidence": "Treatment of PC12 cells stably expressing mutant α-synuclein (A53T) with SMER-10, -18, or-28 significantly reduced levels of mutant α-synuclein, an effect that was enhanced by cotreatment with rapamycin (146).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        }
      },
      "source": 39,
      "target": 76,
      "key": "aba44e843945f88f7d48b660fd77c131e3334fa9d8d1f1eccfe9ebb1627194229c03cc827c60e991d363a061598ccba162c0cecbb08c0bc420a2b13ddc202f59"
    },
    {
      "line": 401,
      "relation": "decreases",
      "evidence": "The DUB USP14 suppresses turnover of Tau and TDP-43 in mouse embryonic fibroblasts (MEFs) by impairing the protea-some;",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "CellLine": {
          "MEF cell line": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 81,
      "target": 71,
      "key": "a271b444ef5d70877bc879a12d941bbc1f7656841a6eefffff8b4c5389a1768ece521c6da1647cfc56f0f09cbf7f2c5ef0857694ae678c785b9cc22a38fa82af"
    },
    {
      "line": 402,
      "relation": "decreases",
      "evidence": "The DUB USP14 suppresses turnover of Tau and TDP-43 in mouse embryonic fibroblasts (MEFs) by impairing the protea-some;",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "CellLine": {
          "MEF cell line": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 81,
      "target": 80,
      "key": "33f2cdf65bcf8b07a3f6395471fd7a9be33a6fd2547ec08ee494481b0e5fba2a670779c2bf9f13aa272194ee7c8212b892062e3cffa8785daba579fc0744d55e"
    },
    {
      "line": 403,
      "relation": "decreases",
      "evidence": "The DUB USP14 suppresses turnover of Tau and TDP-43 in mouse embryonic fibroblasts (MEFs) by impairing the protea-some;",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "CellLine": {
          "MEF cell line": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 81,
      "target": 47,
      "key": "9bfbeaad5917361b228761eab530df9a3e5b582492024cfb8b8937bf16037d41f0b2d5c94c1a7a0cb6d880c309ccb7af2a96bd40f62a437aa8cd83836be3bdcb"
    },
    {
      "line": 408,
      "relation": "decreases",
      "evidence": "Treatment with IU1 reduced the levels of Tau, TDP-43, and ataxin-3 in MEFs in a USP14-dependent manner and independently of changes in proteasome levels or composition (147).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "CellLine": {
          "MEF cell line": true
        }
      },
      "source": 16,
      "target": 71,
      "key": "ac7a8ed03a9c339fa2b4ece85cf05d1f7f1a1ee27564908e16875980bc80cc3f0b32e25427a1363e02cc187deffb0d28b642f08ea7593adb945e0ddccb3a51ca"
    },
    {
      "line": 409,
      "relation": "decreases",
      "evidence": "Treatment with IU1 reduced the levels of Tau, TDP-43, and ataxin-3 in MEFs in a USP14-dependent manner and independently of changes in proteasome levels or composition (147).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "CellLine": {
          "MEF cell line": true
        }
      },
      "source": 16,
      "target": 80,
      "key": "559760c55692ede2d76983c867bfec094156585c18deae2d21dfbc30caf9b38cafe2b2ba3de044ba1eab1c183d6bf44d00db24ddd6149c3670d6c515cfd00182"
    },
    {
      "line": 410,
      "relation": "decreases",
      "evidence": "Treatment with IU1 reduced the levels of Tau, TDP-43, and ataxin-3 in MEFs in a USP14-dependent manner and independently of changes in proteasome levels or composition (147).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "CellLine": {
          "MEF cell line": true
        }
      },
      "source": 16,
      "target": 54,
      "key": "b3ae6cd624102893c6cae3fe3c67f7f852b83eab54f339940b6302b6886978276301e5dab2662a00801b3ecfc72f65b6ca48540b5526ae633f31363c9d9aa2d0"
    },
    {
      "line": 411,
      "relation": "decreases",
      "evidence": "Treatment with IU1 reduced the levels of Tau, TDP-43, and ataxin-3 in MEFs in a USP14-dependent manner and independently of changes in proteasome levels or composition (147).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "CellLine": {
          "MEF cell line": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 16,
      "target": 81,
      "key": "c0082c0115cd7681492126d003b67dc6037b3c8f93c9d793c7ab584267fd394ff333cb43e54fb60f4f6810384833ce4f7c8ec717350dc55f37957fea60efd408"
    },
    {
      "line": 412,
      "relation": "causesNoChange",
      "evidence": "Treatment with IU1 reduced the levels of Tau, TDP-43, and ataxin-3 in MEFs in a USP14-dependent manner and independently of changes in proteasome levels or composition (147).",
      "citation": {
        "type": "PubMed",
        "reference": "25784053"
      },
      "annotations": {
        "Cell": {
          "motor neuron": true
        },
        "CellLine": {
          "MEF cell line": true
        }
      },
      "source": 16,
      "target": 47,
      "key": "8c3c06ef1c933f5f40a0db06fd95503e8dc3ed7b3ddbb3bb64de2fd102d3959ea24fb06d8c463ea43387368523e6527b5656803e4fc4adcb025c0a84858a2718"
    }
  ]
}